WO2014020224A1 - Method for preventing and/or controlling bacterial infections - Google Patents

Method for preventing and/or controlling bacterial infections Download PDF

Info

Publication number
WO2014020224A1
WO2014020224A1 PCT/ES2013/070570 ES2013070570W WO2014020224A1 WO 2014020224 A1 WO2014020224 A1 WO 2014020224A1 ES 2013070570 W ES2013070570 W ES 2013070570W WO 2014020224 A1 WO2014020224 A1 WO 2014020224A1
Authority
WO
WIPO (PCT)
Prior art keywords
methyl ketone
tdc
aliphatic
bacteria
tridecanone
Prior art date
Application number
PCT/ES2013/070570
Other languages
Spanish (es)
French (fr)
Inventor
María Jose SOTO MISFFUT
Joaquina NOGALES DÍAZ
José OLIVARES PASCUAL
Juan SAN JUÁN PINILLA
Original Assignee
Consejo Superior De Investigaciones Científicas (Csic)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior De Investigaciones Científicas (Csic) filed Critical Consejo Superior De Investigaciones Científicas (Csic)
Publication of WO2014020224A1 publication Critical patent/WO2014020224A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N35/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical
    • A01N35/02Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical containing aliphatically bound aldehyde or keto groups, or thio analogues thereof; Derivatives thereof, e.g. acetals
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23BPRESERVING, e.g. BY CANNING, MEAT, FISH, EGGS, FRUIT, VEGETABLES, EDIBLE SEEDS; CHEMICAL RIPENING OF FRUIT OR VEGETABLES; THE PRESERVED, RIPENED, OR CANNED PRODUCTS
    • A23B7/00Preservation or chemical ripening of fruit or vegetables
    • A23B7/14Preserving or ripening with chemicals not covered by groups A23B7/08 or A23B7/10
    • A23B7/153Preserving or ripening with chemicals not covered by groups A23B7/08 or A23B7/10 in the form of liquids or solids
    • A23B7/154Organic compounds; Microorganisms; Enzymes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A23L3/34Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
    • A23L3/3454Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
    • A23L3/3463Organic compounds; Microorganisms; Enzymes
    • A23L3/3481Organic compounds containing oxygen
    • A23L3/3499Organic compounds containing oxygen with doubly-bound oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/121Ketones acyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35Ketones, e.g. benzophenone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Definitions

  • the present invention is encompassed in multiple areas of application, such as Chemistry and Pharmacy, specifically in the field of Agriculture, using the product in question as a phytosatinary intended to reduce diseases in plants caused by bacteria, and prevent foodborne diseases caused for the ingestion of fresh vegetable products contaminated with pathogenic bacteria.
  • the invention also has application in the field of Medicine and Health, to prevent and treat bacterial infections of clinical and veterinary importance in animals and people, as well as in facilities susceptible to contamination by bacteria, such as the food industry.
  • Phytopathogenic bacteria are the causative agent of numerous diseases in plants. These diseases are normally difficult to control, so the measures are aimed primarily at prevention.
  • chemical agents used to control this type of infections are those based on copper such as Bordeaux broth, copper oxychloride or cupric hydroxide.
  • these compounds do not give satisfactory results when the Environmental conditions are optimal for the development and spread of the pathogen.
  • the appearance of bacteria resistant to these compounds is frequent.
  • Another way to fight bacterial infections in plants is to use antibiotics such as streptomycin and oxytetracycline. The drawback of these treatments is that they can not be used on plants intended for human and animal consumption as well as the frequent occurrence of resistance (Agrios 2005. Plant Pathology, 5th edition, Academic Press).
  • the domestic prevention of this type of infections is mainly based on washing thoroughly with water and peeling whenever possible.
  • the use of lemon juice and / or vinegar before consumption seems to be effective in reducing the number of viable cells of some of these pathogens.
  • Producers and distributors usually include practices to eliminate this type of pollutants based on post-harvest disinfectant treatments with chlorine (20-200 ⁇ g / ml), ozone or a combination of both, or ionizing radiation.
  • Another alternative suggested to reduce the risk of contamination consists in the development of agricultural practices that increase bacterial populations in the field that are good competitors against potential pathogens (reviewed in Berger et al. 2010. Environ. Microbiol. 12: 2385-2397 ).
  • 2-Tridecanone 2-Tridecanone (2-TDC, methyl undecyl ketone) is a long-chain aliphatic methyl ketone (Fig. 1). Aliphatic methyl ketones are volatile natural compounds that have been identified in microorganisms, plants, insects and animals (Forney and Markovetz. 1971. The biology of methyl ketones. J. Lipid Res. 12: 383-395).
  • 2-TDC is especially abundant in leaves of wild tomato Solanum habrochaites subsp. glabratum in which it can accumulate in concentrations up to 70 times higher (9.4 ⁇ g of 2-TDC per mg fresh leaf weight) than those found in the cultivable tomato variety (Williams et al. 1980.
  • 2-Tridecanone A Naturally Occurring Insecticide from the Wild Tomato Lycopersicon hirsutum F. glabratum. Science 207: 888-889; Anthonius. 2001. Production and quantification of methyl ketones in wild tomato accessions. J. Environ. Sel Health B 36: 835-848).
  • 2-TDC does not appear to be tomato exclusive and has been identified as a relatively abundant component in the roots of Glossocalyx staudtii, in seeds of Pilocarpus microphyllus and in leaves of Zanthoxylum armatum (Agnaniet et al. 2009. Chemical composition and antimicrobial activity of the essential oils of leaves, roots and bark of Glossocalyx staudtii. Nat. Prod. Commun. 4: 1127-1132; Braga et al. 2007. Insecticidal activity of 2-tridecanone against the cowpea weevil Callosobruchus maculatus (Coleoptera: Bruchidae ) An.Acad.Bras. Cie ⁇ e.
  • 2-TDC has also been identified in animals: as a major component in the secretion of the interdigital glands of the Odocoileus hemionus columbianus deer, where it could participate in semi-chemical communication (Wood et al. 1995. Volatile ketones from interdigital glands of black-tailed deer, Odocoileus hemionus columbianus. J. Chem Ecol.
  • 2-TDC has been identified as a volatile organic compound (VOC) produced by rhizosphere bacteria belonging to the genera Burkholderia r Serratia and Escherichia (Blom et al. 2011. Production of plant growth modulating volatiles is widespread among rhizosphere bacteria and strongly depends on culture conditions. Environ. Microbiol. 13: 3047-3058).
  • 2-TDC The ability of wild tomato species to produce significant amounts of 2-TDC has been linked to the high innate resistance of these plants against the attack of herbivorous insects and mites (Williams et al. 1980.
  • 2- Tridecanone A Naturally Occurring Insecticide from the Wild Tomato Lycopersicon hirsutum ⁇ .glabratum. Science 207: 888-889; Weston et al. 1989. Trichome secretion composition, trichome densities, and spider mite resistance of 10 accessions of Lycopersicon hirsutum.
  • bacterial infections can cause more or less serious diseases in plants and animals, including humans.
  • the importance of prevention, control and, where appropriate, treatment of infections caused by pathogenic bacteria in humans is obvious. Equally important is to prevent and control the diseases caused by bacteria in animals since some of these infections can generate from large losses in the livestock sector, to food poisoning or even the transmission of the disease to man.
  • plant diseases caused by bacteria or bacteriosis are responsible for significant losses in agriculture.
  • phytopathogenic bacteria generally cannot cause disease in animals, in recent years evidence has accumulated that fruits, herbs, vegetables, and especially green leafy vegetables, are authentic reservoirs of enteropathogenic bacteria such as enteric Salmonella or Escherichia coli
  • enteropathogenic bacteria such as enteric Salmonella or Escherichia coli
  • the origin of the infection can be diverse, with irrigation water being the main route of contamination. Since this type of food is usually consumed raw or with very little processing, the presence in them of this type of pathogens constitutes a risk to human health.
  • the present invention provides a new agent for the prevention and control of bacterial infections that cause diseases in both plants and animals and humans.
  • the compound is 2-tridecanone (2-TDC), a long-chain aliphatic methyl ketone (Fig. 1), produced naturally by plants, animals and bacteria.
  • 2-TDC 2-tridecanone
  • Fig. 1 a long-chain aliphatic methyl ketone
  • the present invention relates, in a first object, to a method for preventing and / or controlling bacterial infections in a plant and / or crop, characterized in that it comprises administering a long aliphatic chain methyl ketone of general formula (I):
  • the action of "controlling” is understood as avoiding additional infections to those already existing, it being not found that the compound in question has a treatment effect whereby already established infections are eliminated.
  • the term “long aliphatic chain” refers in the present invention to a chain formed by a number comprised between 9 and 13 carbon atoms.
  • a second object of protection is constituted by a method to prevent and / or control infections caused by pathogenic bacteria of animals and humans that could be found contaminating food production facilities and food treatment, containment facilities, transport and care of animals, and in Medical materials and facilities likely to be contaminated with pathogenic bacteria, by applying the aliphatic long chain methyl ketones described above.
  • a third object of protection consists in the use of the aliphatic long chain methyl ketones of general formula (I) defined above, such as methyl ketone 2-tridecanone, in the prevention and / or control of bacterial infections both in the phytosanitary field, such as in the field of Hygiene and Health of facilities, food or in the manufacture of consumable products, among other uses.
  • a fourth object of protection refers to the aliphatic long chain methyl ketone of general formula (I) defined above, such as methyl ketone 2-tridecanone, for use in medicine, and more particularly particularly preferably to its use in prevention and / or treatment of bacterial infections in a subject.
  • methyl ketone is described herein, and more specifically 2-tridecanone, for use in medicine, and preferred embodiments of said methyl ketone, it should be understood that the invention also relates to or covers the use of methyl ketone in medicine.
  • an object on which 2-tridecanone or another aliphatic long chain methyl ketone of general formula (I) is applied is "susceptible to being contaminated by bacteria" when said object, be it a plant, an animal , a human being, a product or an installation presents a risk of contagion, for any reason (sensitivity, exposure ).
  • the invention is based on the application / administration of the natural organic aliphatic long chain methyl ketone compound of general formula (I), with 2-tridecanone (2-TDC) being the best example, to individuals (plants , animals, humans), products or facilities at risk of bacterial contamination that may lead to the development of a disease.
  • the invention is about the use of 2-tridecanone or other aliphatic long chain methyl ketone of formula (I) in the prevention and treatment of bacterial infections, both in plants, as in animals, humans and even facilities and Foods likely to be affected by bacteria contamination.
  • Each of these applications is treated separately here, depending on the application object.
  • the main advantage of using aliphatic long chain methyl ketones defined by formula (I) is that they are natural compounds produced by numerous organisms, including plants and animals, of low or no impact on the environment. So far no harmful effects of these compounds have been described, especially 2-TDC on living organisms. This compound is available in the market and is not an expensive product (Alfa Aesar 83.6 euros / 100 g) ⁇
  • methyl ketones described herein are biodegradable (there are bacteria capable of using 2-TDC as a carbon source). All this implies that their use does not generate problems from an environmental point of view and is free of risks to human and animal health. This result is of double interest in the field of technology for the following reasons: first, it is unexpected because there are documents in the state of the art that suggest the absence of a significant and interesting effect of long chain methyl ketones aliphatic in bacteria and the infections they cause.
  • Wood et al (1995; Volatile ketones from interdigital glands of black-tailed deer, Odocoileus hemionus columbianus. J. Chem Ecol.
  • the long aliphatic methyl ketone chain of general formula (I) is a linear aliphatic chain.
  • linear chain refers in the present invention to a chain formed by a number comprised between 9 and 13 carbon atoms bonded together by C-C covalent bonds, complemented its structure with hydrogen bonds.
  • linear aliphatic chain is saturated.
  • saturated chain refers in the present invention to a carbon chain in which there is no double or triple bond.
  • the aliphatic long chain methyl ketone of general formula (I) is selected from the group consisting of 2-tridecanone, 2-dodecadone, 2-pentadecanone and 2-undecanone.
  • the methyl ketone is 2-tridecanone.
  • the use of the invention as a phytosanitary product It is of special interest, although not limited to the invention, in the application of the aliphatic long chain methyl ketones defined herein, such as 2-TDC, in plants or crops that do not produce significant amounts of these compounds during times of risk, to protect them from bacterial infections that can potentially cause them harm or disease. Since there are few plants in which the significant production of these compounds has been described, the invention is potentially useful for all types of plants.
  • the methyl ketone described can be administered in diluted form in a liquid. Preferably, it is administered as a solution. More preferably still, the aliphatic long chain methyl ketone of general formula (I) is diluted in the solution in a concentration between 1 ⁇ and 10 mM, including both limits, and in the most preferred case is between 5 ⁇ and 500 ⁇ , including both limits. Also preferably, the solution containing the compound in question is an ethanolic solution.
  • Said ethanolic solution is preferably 0.1% ethanol (v / v, ethanol / water), such that 1 L of solution containing the active compound methyl ketone at a concentration of 50 ⁇ would contain 999 ml of water, 1 ml of ethanol and: 2-TDC mg previously dissolved in ethanol, or 8.5 mg of 2-undecanone; or 9.2 mg for 2-dodecanone; and 11.32 mg for 2- pentadecanone.
  • the aliphatic long chain methyl ketone of formula (I), such as 2-tridecanone is applied by spraying (spray) the aerial part of the plant with the solution, which is preferably 0.1% ethanolic ( v / v, ethanol / water), containing effective concentrations of the compound. It is sprayed trying to make the surface to be treated homogeneously moistened.
  • the solution is injected directly into the plant stem, by methods conventional.
  • the invention involves the direct administration of the methyl ketone solution defined above to the soil or other plant growth medium.
  • Administration can be indirectly through irrigation water or a nutrient solution for the plant, or by immersion of the root system or of the entire plant (or seeds) in the solution with 2- tridecanone or other methyl ketone long aliphatic chain of general formula (I).
  • the solution would be prepared as indicated above, being able to replace the water with nutrient solution for plant growth.
  • the applications of the compound on the plant or the cultivation soil or other growth medium will be carried out in non-phytotoxic concentrations, preferably at times of the year of maximum risk, and several applications can be made spaced over time .
  • the phytotoxic concentration to be used will depend on the type of plant and the mode of administration, since for example it has been found that at similar concentrations, in a hydroponic way the phytotoxic effect is more pronounced than in aerial spraying, always within the intervals defined in this memory.
  • the maximum effectiveness of the methyl ketone of general formula (I) was obtained using concentrations between 1 ⁇ and 10 mM, including both limits, although obviously the optimum concentration of the compound to exert its protective effect depended on the type of plant, phase of its development, as well as the frequency and form of application.
  • concentrations between 1 ⁇ and 10 mM, including both limits, although obviously the optimum concentration of the compound to exert its protective effect depended on the type of plant, phase of its development, as well as the frequency and form of application.
  • the effect of methyl ketone of general formula (I) on the limitation of bacterial infections at lower concentrations (minimum 4.4 times lower) than those described as non-phytotoxic after spray application has been demonstrated, which means a big advantage.
  • 2-TDC or other methyl ketone of general formula (I) can be applied alone or mixed with other additives known and commonly used in the field of Agriculture, for example organic and / or inorganic fertilizers, insecticides, nematicides, fungicides , bactericides and herbicides, and any combination thereof. Methyl ketone can be applied to plants before, after or simultaneously to the mentioned pesticides, herbicides or the like.
  • the product to be treated can be of a very diverse nature: food, surgical equipment ... or it can be an installation susceptible to contamination by bacteria (food production and treatment, containment, transport and care of animals, hospitals and health centers , kitchens, cooling systems or towers, humidifiers ).
  • This method is aimed primarily, but not limited to, products from the fruit and vegetable sector, in order to interfere with the mechanisms of infection of potential pathogens that were contaminating the edible plant material.
  • this method can also be used in other products that may be contaminated, such as those of animal origin: eggshell ...
  • the administration of the compound can be done after its collection, and always in concentrations not toxic to human consumption.
  • the method is carried out by immersing the entire product in a solution of the active compound as described herein, in any of its variants.
  • the recommended and most preferable form includes spraying the product intended for consumption or the relevant installation with an ethanolic solution containing concentrations between 1 ⁇ and 10 mM or more specific, as described herein. .
  • the air conditioning system and / or the cooling system of the installation to be treated is used to administer the solution containing the 2-tridecanone or other methyl ketone of the general formula (I).
  • the present invention is also directed to the use of methyl ketone of general formula (I), such as 2-tridecanone, for preventing and / or treating bacterial infections for phytosanitary purposes, that is in plants and / or crops.
  • the use of 2-tridecanone or another aliphatic long-chain methyl ketone is directed to the prevention and / or control of infections against Pvaudomonas syringae, P. savastanoi, Clavibacter michiganensis r Xanthomonas campestris, X. citri, Xylella fastidiosa , Ralstonia solanacearum, Agrobacterium turnefaciens or Erwinia amylovora.
  • 2-tridecanone or other methyl ketone of general formula (I) to prevent and / or control infections caused by pathogenic bacteria of animals and humans that could be found contaminating food products and / or facilities for producing said foods.
  • these products may be of vegetable origin, such as fruit and vegetable products, or of animal origin, such as eggs.
  • methyl ketone of general formula (I), such as 2-tridecanone also covers the prevention of infections caused by bacteria that could be found contaminating animal containment and transport facilities, as well as medical facilities and hospital and the material used in them (for example, surgical material, catheters ...) or in other areas susceptible to contamination by bacteria, such as kitchens.
  • methyl ketone of general formula (I) is for the prevention of surface biofilms, by administration on said surface of a material.
  • Another object of the present invention is the use of 2-tridecanone or another methyl ketone of formula (I) as an additive against bacterial infections in oral hygiene products (dentifrices, mouthwashes) or body hygiene (hand soap).
  • the subject susceptible to being contaminated by Bacteria can be a human being or an animal.
  • the 2-tridecanone or other aliphatic long chain methyl ketone is preferably administered in the form of a solution, this being more preferably an ethanolic solution.
  • the methyl ketone of formula (I) is contained in the solution in a concentration between 1 ⁇ and 10 mM, including both limits, being more preferably between 5 ⁇ and 500 ⁇ , including both limits.
  • Said ethanolic solution is preferably 0.1% ethanol (v / v, ethanol / water).
  • the methyl ketone of general formula (I), especially 2-tridecanone is administered against Salmonella typhimurium, enteropathogenic Escherichia coli, Proteus mirabilis r Pseudomonas aeruginosa, Legionella pneumophila.
  • administration can be performed for example by topical application of open wounds, orally (to avoid gastrointestinal infections) or by inhalation devices (avoid respiratory infections), although it can be performed by any known and customary method in the field for this type of compounds.
  • Administration is preferably carried out in the amounts and formats mentioned above: in a solution that is preferably ethanolic, at a concentration between 1 ⁇ and 10 mM, including both limits, more preferably between 5 ⁇ and 500 uM, including both limits, etc. .
  • FIG. 3 Effect of 2-TDC on the biofilm formation capacity of P. syringae pv. syringae BTlll.
  • FIG. 4 Protective effect of 2-TDC on the development of the black spot of tomato. Development of leaf necrosis of tomato plants treated with the control mixtures C + Mb and E + Eb, and treated with 2 different concentrations of 2-TDC (T + MTlb and T + MT10b).
  • Figure 5. Effect of the treatment of tomato plants with 2- TDC on the survival over time of the P. syringae pv tomato DC3000 bacteria in leaf tissue (expressed as colony forming units (cfu) per cm 2 ). The symbols represent survival in plants treated with C + Mb (circle), E + Mb (rhombus), T + MTlb (square), or T + MT10b (triangle).
  • Figure 6. Inhibitory effect of 2-TDC on nodule formation in alfalfa plants by Sinorhizobium meliloti bacteria, strain GR4.
  • FIG. 7 Effect caused by different methyl ketones on the surface motility of Sinorhizobium meliloti GR4 and Pseudomonas syringae pv syringae BT111.
  • the graph shows the average surface dispersion halo of Sm GR4 (gray bars) and Pss BT111 (black bars) after 24 hours of incubation in the absence of methyl ketones (control), in the presence of ethanol (E), or in the presence of 2-undecanone (2- UDC), 2-dodecanone (2-DDC), 2-tridecanone (2-TDC) or 2- pentadecanone (2-PDC).
  • the error bars represent the standard error and different letters indicate statistically significant differences according to an ANOVA test (P ⁇ 0.05).
  • Example 1 Protective efficacy of the application of 2-TDC in the appearance of the black spot of tomato caused by the phytopathogenic bacterium Pseudomonas syringae pv. tomato DC3000.
  • Tomato ⁇ Solanum lycopersicum "Moneymaker” was used as plant material. The seeds germinated and grew in seedbeds with composted peat in a growth chamber under controlled conditions of light, T a and humidity for 3 weeks. Subsequently, they were individually transplanted in plastic pots 14 cm in diameter and 13 cm high, stuffed with peat, where they remained 2 more weeks, before proceeding to infection with the bacteria.
  • the strain DC3000 of Pseudomonas syringae pv. tomato (Pst).
  • the bacterium was grown at 28 ° C in solid LB medium (1% tryptone, 0.5% yeast extract, 0.5% NaCl, 1.5% bacteriological agar), added rifampin (Rif) (10 mg / L). From these plates, a bacterial suspension was prepared in a solution of 10 mM MgCl 2 resuspending bacterial mass until reaching an optical density (DC> 6oonm) of 0.3-0.4 (corresponds to approximately 10 8 colony forming units (CFU) / me) .
  • DC> 6oonm optical density
  • CFU colony forming units
  • the chemical treatment with 2-TDC was carried out in 2 stages: i) Addition of 40 mg of 2-TDC (equivalent to about 26 kg of the compound / Hectare) to the substrate (peat) of each pot, 24 hours before the application of the pathogen and ii) foliar application by spraying two different concentrations of the compound (50iM and 5001M) at the same time of application of the pathogenic bacteria. It has been proven that these concentrations of 2-TDC do not generate appreciable adverse effects on bacterial growth in pure culture. Nor have harmful effects been observed in the development of the plant.
  • the pots were watered with 25 ml of solution T, E or C that was applied around the plant stem. Immediately afterwards, an additional 25 ml of sterile water was applied to allow a good penetration of the treatments in the substrate.
  • -Mix M 40 ml of a 10 mM MgCl 2 solution
  • -Me mix 40 ml of M mixture containing 40 ⁇ of ethanol.
  • - MT1 Mix 40 ml of mixture M containing 40 ⁇ of a stock solution of 50 mM 2-TDC (prepared by dissolving 10 mg of 2-TDC per ml of EtOH).
  • -Meb mix 40 ml of Mb mixture containing 40 ⁇ of ethanol.
  • - MTlb Mix 40 ml of Mb mixture containing 40 ⁇ of a 50 mM 2-TDC stock solution (prepared by dissolving 10 mg of 2-TDC per ml of EtOH).
  • the substrate was irrigated with Sol. T (10 pots), Sol. E (5 pots) and Sol. C (5 pots).
  • Fig. 4 shows the appearance of the plants after 10 days after performing the different treatments. Plants that were treated with 2-TDC (MTlb and MTlOb) developed much less necrotic spots on the leaves than control plants (Mb and Eb). The effect was also dose-dependent, since the plants treated with the more concentrated 2-TDC solution (MTlOb) showed a better appearance than those treated with a lower concentration dose, the development of necrotic spots being almost negligible. The 2-TDC treatment also had an effect on bacterial survival in plant tissues (Fig. 5).
  • Example 2 Application of 2-TDC in nutrient solution to reduce infection caused by Sinorhizobium meliloti bacteria in alfalfa plants.
  • Alfalfa Medicago sativa var. Aragon
  • the seeds were surface sterilized and germinated as described in Olivares et al. (1980).
  • the germinated seeds were placed in glass tubes (2 x 20 cm) containing a filter paper and 10 ml of nutrient solution for nitrogen-free plants (Rigaud and Puppo, 1975). After spending 2 days in the dark, the plants were moved to a growth chamber under controlled conditions of light, T a and humidity, in which they were incubated 1 week before proceeding to inoculation with the bacteria.
  • strain GR4 of Sinorhizobium meliloti was used as a bacterium capable of infecting alfalfa.
  • the inoculum was prepared by growing the bacteria in liquid TY medium (Beringer, 1974) to 30 ° C until reaching an optical density (DC> 6oonm) of 0.5-0.6 (approximately 5 x 10 8 cfu / ml).
  • This inoculum was diluted in sterile water to obtain an inoculum density of 5 x 10 6 cfu / ml, suspension with which the inoculation of the plants would be performed.
  • the bacteria were inoculated, adding to each tube / plant 1 ml of the prepared bacterial suspension as previously mentioned.
  • 2-TDC treatments or control treatments were performed at the time of inoculation with the bacteria.
  • two stock solutions of 2-TDC were prepared using ethanol as solvent: at 25 mM (5 mg of 2-TDC / ml of ethanol) and 5 mM (1 mg of 2-TDC / ml of ethanol). 10 ⁇ of one of these solutions were applied to the 10 ml of nutrient solution (1: 1000 dilution) in which the plants grow, leaving therefore the compound in a concentration of 25 ⁇ and 5 ⁇ , respectively.
  • the success of the bacterial infection was determined by performing a daily count of the nodules (organ induced and colonized by S. meliloti) developed by plant. The results obtained in 2 independent experiments are shown in Fig. 6 of this report.
  • the data suggest that the application of ethanol at a concentration of 0.1% to the nutrient solution in which the plants grow can cause a delay in the appearance of nodules, as well as a significant reduction in the average number of nodules per plant, which does not However, it recovers over time, until reaching similar values to those obtained in plants in which no treatment has been applied.
  • the application of the ethanolic solution containing 2-TDC causes a delay and a reduction in the number of nodules, effects that are significantly superior to those obtained with the control treatment, and also dose dependent.
  • the application of the more concentrated solution of 2-TDC caused a delay of 4-6 days in the appearance of the first nodules, as well as a reduction of almost 50% in the number of nodules developed.
  • Example 3 Comparison of the effect caused by 2-undecanone, 2-dodecanone and 2-pentadecanone methyl ketones with that generated by 2-tridecanone in the swarming motility of the Sinorhizobium meliloti GR4 and Pseudomonas syringae patovar syringae BTlll bacteria.
  • surface motility tests of S. meliloti GR4 and P. syringae pv bacteria were performed. syringae BTlll, in the absence and presence of these compounds.
  • the surface motility test was basically performed as described in Nogales et al. 2010 BMC Genomics 11: 157, with the sole caveat that the semi-solid minimum medium (MM) was prepared by adding 0.6% Difco noble agar (BD) instead of 0.6% purified agar (Pronadisa). The plates were allowed to solidify and dry for 15 minutes in a laminar flow cabinet with the lid open before applying the inoculum.
  • MM semi-solid minimum medium
  • BD Difco noble agar
  • Pronadisa purified agar
  • the solutions containing each of the methyl ketones were prepared by dissolving 50 ⁇ of each compound in 1 ml of ethanol, that is, 8.5 mg of 2-undecanone (2-UDC), 9.2 mg of 2-dodecanone (2- DDC), 10 mg of 2-tridecanone (2-TDC) or 11.32 mg of 2-pentadecanone (2-PDC).
  • the bacteria were grown in liquid TY medium (Beringer, 1974) at 30 ° C until an optical density (DC> 6oonm) of 0.9-1 was reached. Under aseptic conditions, 1 mL of these cultures was taken and the cells were collected by centrifugation (2 min, 10,000 rpm in a microcentrifuge), discarding the cell-free culture medium. The cell precipitate was washed twice with 1 ml of liquid MM (Robertsen et al. 1981) and finally resuspended in 100 ⁇ of the same medium.
  • Example 4 Application of 2-TDC on the surface of food for human or animal consumption to avoid diseases caused by pathogenic bacteria that are contaminating the food.
  • the food is collected, which in this case can be a fruit and vegetable product (fruits, vegetables, herbs ...) or an animal product such as eggs that can be contaminated with enteropathogenic bacteria such as Salmonella.
  • the products are passed through a belt on which a rain of an aqueous solution containing 2-TDC is applied at a final concentration of 50-500 ⁇ M.
  • Each liter of solution contains 999 ml of water, 1 ml of ethanol and 10-100 mg of 2-TDC previously dissolved in ethanol.
  • food can be dipped in pails containing the same solution. Once impregnated, they are allowed to dry at room temperature before packing.
  • Example 5 Use of inhalers containing 2-TDC in the prevention of bacterial respiratory diseases in patients at risk (immunosuppressed, recurrent infections ).

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Environmental Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dentistry (AREA)
  • Nutrition Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The invention relates to a method for preventing and/or controlling bacterial infections in a plant and/or culture, and to products (raw food, washing solutions, material for use in hospitals) and facilities that are susceptible to contamination by bacteria, by means of the application of long-chain aliphatic methyl ketones, essentially 2-tridecanone but also 2-undecanone, 2-dodecanone, and 2-pentadecanone, in non-toxic forms and concentrations of a micromolar order such that they enable the prevention of said infection without producing a bactericide effect (destruction of bacteria). The invention also relates to said methyl ketones for use in medicine, by means of the administration of said compound to an animal or a human being.

Description

MÉTODO PARA PREVENIR Y/O CONTROLAR INFECCIONES BACTERIANAS  METHOD TO PREVENT AND / OR CONTROL BACTERIAL INFECTIONS
Campo de la invención Field of the Invention
La presente invención se engloba en múltiples áreas de aplicación, como puede ser el de Química y Farmacia, concretamente en el campo de la Agricultura, empleándose el producto en cuestión como fitosatinario destinado a reducir enfermedades en plantas causadas por bacterias, y prevenir enfermedades alimentarias causadas por la ingestión de productos vegetales frescos contaminados con bacterias patógenas. La invención también tiene aplicación en el campo de la Medicina y en el de Sanidad, para prevenir y tratar infecciones bacterianas de importancia clínica y veterinaria en animales y personas, así como en instalaciones susceptibles de contaminación por bacterias, como es la Industria alimentaria. The present invention is encompassed in multiple areas of application, such as Chemistry and Pharmacy, specifically in the field of Agriculture, using the product in question as a phytosatinary intended to reduce diseases in plants caused by bacteria, and prevent foodborne diseases caused for the ingestion of fresh vegetable products contaminated with pathogenic bacteria. The invention also has application in the field of Medicine and Health, to prevent and treat bacterial infections of clinical and veterinary importance in animals and people, as well as in facilities susceptible to contamination by bacteria, such as the food industry.
Estado de la técnica State of the art
Control de enfermedades de plantas causadas por bacteriasControl of plant diseases caused by bacteria
(bacteriosis ) (bacteriosis)
La forma más frecuente y habitual de proteger las plantas frente al ataque de patógenos ha estado basada en el uso masivo de pesticidas. El daño que ocasionan estos compuestos químicos al medio ambiente así como sus riesgos potenciales para la salud animal y humana, obligan a la búsqueda de soluciones alternativas para la protección de los cultivos. The most frequent and usual way to protect plants against the attack of pathogens has been based on the massive use of pesticides. The damage caused by these chemical compounds to the environment as well as their potential risks to animal and human health, require the search for alternative solutions for crop protection.
Las bacterias fitopatógenas son el agente causal de numerosas enfermedades en plantas. Dichas enfermedades son normalmente difíciles de controlar por lo que las medidas van dirigidas fundamentalmente a la prevención. Entre los agentes químicos que se usan para controlar este tipo de infecciones se encuentran los basados en cobre como el caldo bordelés, oxicloruro de cobre o hidróxido cúprico. Sin embargo, estos compuestos no dan resultados satisfactorios cuando las condiciones ambientales son las óptimas para el desarrollo y la diseminación del patógeno. Además es frecuente la aparición de bacterias resistentes a estos compuestos. Otra forma de combatir las infecciones bacterianas en plantas consiste en usar antibióticos como la estreptomicina y la oxitetraciclina . El inconveniente de estos tratamientos es que no pueden usarse en plantas destinadas al consumo humano y animal, asi como la aparición frecuente de resistencias (Agrios 2005. Plant Pathology, 5a edición, Academic Press) . Phytopathogenic bacteria are the causative agent of numerous diseases in plants. These diseases are normally difficult to control, so the measures are aimed primarily at prevention. Among the chemical agents used to control this type of infections are those based on copper such as Bordeaux broth, copper oxychloride or cupric hydroxide. However, these compounds do not give satisfactory results when the Environmental conditions are optimal for the development and spread of the pathogen. In addition, the appearance of bacteria resistant to these compounds is frequent. Another way to fight bacterial infections in plants is to use antibiotics such as streptomycin and oxytetracycline. The drawback of these treatments is that they can not be used on plants intended for human and animal consumption as well as the frequent occurrence of resistance (Agrios 2005. Plant Pathology, 5th edition, Academic Press).
Una alternativa a estos tratamientos que está siendo investigada en los últimos años es el uso de péptidos antimicrobianos bien producidos por organismos vivos, bien sintéticos (Marcos et al. 2008. Annu . Rev. Phytopathol . 46:273-301) . Los principales inconvenientes de su uso en el control de bacteriosis están en su limitada eficacia in vivo ya que son degradados por proteasas de los tejidos vegetales, o bien en su alto coste económico en el caso de los sintéticos . An alternative to these treatments that is being investigated in recent years is the use of antimicrobial peptides that are well produced by living, very synthetic organisms (Marcos et al. 2008. Annu. Rev. Phytopathol. 46: 273-301). The main drawbacks of its use in the control of bacteriosis are in its limited efficacy in vivo since they are degraded by proteases of plant tissues, or in their high economic cost in the case of synthetics.
Prevención de enfermedades alimentarias causadas por la ingestión de productos vegetales frescos contaminados con bacterias patógenas En los últimos años se han constatado numerosas evidencias que indican que frutas, hierbas, hortalizas, y en especial las verduras de hoja verde, son auténticos reservorios de bacterias enteropatógenas como Salmonella entérica o Escherichia coli (Berger et al. 2010. Environ. Microbiol. 12:2385-2397) . El origen de la infección puede ser diverso, siendo el agua de riego, la principal vía de contaminación. Puesto que este tipo de alimentos se suelen consumir crudos o con muy poca elaboración, la presencia en ellos de este tipo de patógenos constituye un riesgo para la salud humana. Un ejemplo cercano de este problema lo hemos tenido en la crisis alimentaria que tuvo lugar en Alemania en el año 2011 causada por una cepa agresiva de E. coli que provocó la muerte de varias personas y la intoxicación de varios centenares. El origen de esta intoxicación fue inicialmente atribuido a partidas de pepino de origen español, lo que ocasionó una alarma que, aunque posteriormente desmentida, causó graves pérdidas en el sector hortofruticola español. Prevention of food diseases caused by the ingestion of fresh plant products contaminated with pathogenic bacteria In recent years there have been numerous evidences that indicate that fruits, herbs, vegetables, and especially green leafy vegetables, are authentic reservoirs of enteropathogenic bacteria such as Enteric salmonella or Escherichia coli (Berger et al. 2010. Environ. Microbiol. 12: 2385-2397). The origin of the infection can be diverse, with irrigation water being the main route of contamination. Since this type of food is usually consumed raw or with very little processing, the presence in them of this type of pathogens constitutes a risk to human health. We have had a close example of this problem in the food crisis that took place in Germany in 2011 caused by an aggressive strain of E. coli that caused the death of several people and the poisoning of several hundreds. He The origin of this poisoning was initially attributed to cucumber items of Spanish origin, which caused an alarm that, although later denied, caused serious losses in the Spanish fruit and vegetable sector.
La prevención doméstica de este tipo de infecciones se basa fundamentalmente en lavar abundantemente con agua y pelar siempre y cuando sea posible. El uso de zumo de limón y/o vinagre antes del consumo, parecen ser eficaces en reducir el n° de células viables de algunos de estos patógenos. Productores y distribuidores suelen incluir prácticas para eliminar este tipo de contaminantes basadas en tratamientos desinfectantes post-cosecha con cloro (20-200 μg/ml), ozono o una combinación de ambos, o radiaciones ionizantes. Otra alternativa sugerida para disminuir el riesgo de contaminación consiste en el desarrollo de prácticas agrícolas que incrementen poblaciones bacterianas en la filosfera que sean buenas competidoras frente a los potenciales patógenos (revisado en Berger et al. 2010. Environ. Microbiol. 12:2385-2397) . The domestic prevention of this type of infections is mainly based on washing thoroughly with water and peeling whenever possible. The use of lemon juice and / or vinegar before consumption seems to be effective in reducing the number of viable cells of some of these pathogens. Producers and distributors usually include practices to eliminate this type of pollutants based on post-harvest disinfectant treatments with chlorine (20-200 μg / ml), ozone or a combination of both, or ionizing radiation. Another alternative suggested to reduce the risk of contamination consists in the development of agricultural practices that increase bacterial populations in the field that are good competitors against potential pathogens (reviewed in Berger et al. 2010. Environ. Microbiol. 12: 2385-2397 ).
Control de las enfermedades infecciosas en animales y humanos causadas por bacterias El procedimiento más habitual y efectivo en el tratamiento de infecciones bacterianas en animales y humanos consiste en la administración de antibióticos. Los antibióticos actúan provocando la muerte de la bacteria o bien impidiendo su multiplicación. El uso, a veces indiscriminado, de estos fármacos está dando lugar a la aparición de bacterias resistentes a la acción de los antibióticos más habituales ( super-bugs) . Las enfermedades causadas por bacterias resistentes suelen ser muy graves porque son difíciles de tratar. En el mejor de los casos, conllevan a un incremento en el coste del tratamiento, ya que hay que hacer uso de productos antibióticos de nueva generación frente a los cuales aún no hayan aparecido resistencias. En el caso de resistencias a antibióticos beta-lactámicos , está dando buen resultado el tratamiento conjunto del beta-lactámico con un inhibidor de beta-lactamasas , enzimas producidas por la bacteria que inactivan el antibiótico. También parecen ser efectivas las terapias con fagos o productos de fagos, para tratar o incluso prevenir infecciones bacterianas (Hermoso et al. 2007. Curr. Opin. Microbiol. 10:461-472) . Control of infectious diseases in animals and humans caused by bacteria The most common and effective procedure in the treatment of bacterial infections in animals and humans is the administration of antibiotics. Antibiotics act causing the death of the bacteria or preventing their multiplication. The sometimes indiscriminate use of these drugs is leading to the emergence of bacteria resistant to the action of the most common antibiotics (super-bugs). Diseases caused by resistant bacteria are usually very serious because they are difficult to treat. In the best case, they lead to an increase in the cost of treatment, since it is necessary to make use of new generation antibiotic products against which resistance has not yet appeared. In the case of resistance to beta-lactam antibiotics, it is giving good The combined treatment of beta-lactam with an inhibitor of beta-lactamases, enzymes produced by the bacteria that inactivate the antibiotic. Phage therapies or phage products also appear to be effective in treating or even preventing bacterial infections (Hermoso et al. 2007. Curr. Opin. Microbiol. 10: 461-472).
2-tridecanona La 2-tridecanona (2-TDC, metil undecil cetona) es una metilcetona de larga cadena alifática (Fig. 1) . Las metil cetonas alifáticas son compuestos naturales volátiles que han sido identificados en microorganismos, plantas, insectos y en animales (Forney and Markovetz. 1971. The biology of methyl ketones. J. Lipid Res. 12:383-395) . 2-Tridecanone 2-Tridecanone (2-TDC, methyl undecyl ketone) is a long-chain aliphatic methyl ketone (Fig. 1). Aliphatic methyl ketones are volatile natural compounds that have been identified in microorganisms, plants, insects and animals (Forney and Markovetz. 1971. The biology of methyl ketones. J. Lipid Res. 12: 383-395).
La 2-TDC es especialmente abundante en hojas de especies silvestres de tomate Solanum habrochaites subsp. glabratum en las que se puede acumular en concentraciones hasta 70 veces superiores (9.4 μg de 2-TDC por mg peso fresco de hoja) a las encontradas en la variedad cultivable de tomate (Williams et al. 1980. 2-Tridecanone : A Naturally Occurring Insecticide from the Wild Tomato Lycopersicon hirsutum f . glabratum. Science 207 : 888-889; Anthonius . 2001. Production and quantification of methyl ketones in wild tomato accessions. J. Environ. Sel Health B 36:835-848) . No obstante, la 2-TDC no parece ser exclusiva de tomate y se ha identificado como un componente relativamente abundante en las raices de Glossocalyx staudtii , en semillas de Pilocarpus microphyllus y en hojas de Zanthoxylum armatum (Agnaniet et al. 2009. Chemical composition and antimicrobial activity of the essential oils of leaves, roots and bark of Glossocalyx staudtii. Nat. Prod. Commun. 4:1127-1132; Braga et al. 2007. Insecticidal activity of 2-tridecanone against the cowpea weevil Callosobruchus maculatus (Coleóptera: Bruchidae) An.Acad.Bras. Cieñe. 79:35-39; Bisht and Chanotiya. 2011. 2- undecanone rich leaf essential oil from Zanthoxylum armatum. Nat Prod. Commun. 6:111-114) . También se ha identificado 2-TDC en animales: como componente mayoritario en la secreción de las glándulas interdigitales del ciervo Odocoileus hemionus columbianus, donde podría participar en comunicación semioquímica (Wood et al. 1995. Volatile ketones from interdigital glands of black-tailed deer, Odocoileus hemionus columbianus. J. Chem Ecol . 21:1401-1408), y en glándulas mandibulares de abejas obreras donde parece actuar como feromona que induce respuestas agresivas en el insecto (Schorkopf et al. 2009. Mandibular gland secretions of meliponine worker bees: further evidence for their role in interspecific and intraspecific defence and aggression and against their role in food source signalling. J. Exp. Biol. 212:1153-1162) . Más recientemente, la 2-TDC se ha identificado como un compuesto orgánico volátil (VOC) producido por bacterias de la rizosfera pertenecientes a los géneros Burkholderia r Serratia y Escherichia (Blom et al. 2011. Production of plant growth modulating volátiles is widespread among rhizosphere bacteria and strongly depends on culture conditions. Environ. Microbiol. 13:3047-3058) . 2-TDC is especially abundant in leaves of wild tomato Solanum habrochaites subsp. glabratum in which it can accumulate in concentrations up to 70 times higher (9.4 μg of 2-TDC per mg fresh leaf weight) than those found in the cultivable tomato variety (Williams et al. 1980. 2-Tridecanone: A Naturally Occurring Insecticide from the Wild Tomato Lycopersicon hirsutum F. glabratum. Science 207: 888-889; Anthonius. 2001. Production and quantification of methyl ketones in wild tomato accessions. J. Environ. Sel Health B 36: 835-848). However, 2-TDC does not appear to be tomato exclusive and has been identified as a relatively abundant component in the roots of Glossocalyx staudtii, in seeds of Pilocarpus microphyllus and in leaves of Zanthoxylum armatum (Agnaniet et al. 2009. Chemical composition and antimicrobial activity of the essential oils of leaves, roots and bark of Glossocalyx staudtii. Nat. Prod. Commun. 4: 1127-1132; Braga et al. 2007. Insecticidal activity of 2-tridecanone against the cowpea weevil Callosobruchus maculatus (Coleoptera: Bruchidae ) An.Acad.Bras. Cieñe. 79: 35-39; Bisht and Chanotiya. 2011. 2- undecanone rich leaf essential oil from Zanthoxylum armatum. Nat Prod. Commun. 6: 111-114). 2-TDC has also been identified in animals: as a major component in the secretion of the interdigital glands of the Odocoileus hemionus columbianus deer, where it could participate in semi-chemical communication (Wood et al. 1995. Volatile ketones from interdigital glands of black-tailed deer, Odocoileus hemionus columbianus. J. Chem Ecol. 21: 1401-1408), and in mandibular glands of worker bees where it seems to act as a pheromone that induces aggressive responses in the insect (Schorkopf et al. 2009. Mandibular gland secretions of meliponine worker bees: further evidence for their role in interspecific and intraspecific defense and aggression and against their role in food source signalling. J. Exp. Biol. 212: 1153-1162). More recently, 2-TDC has been identified as a volatile organic compound (VOC) produced by rhizosphere bacteria belonging to the genera Burkholderia r Serratia and Escherichia (Blom et al. 2011. Production of plant growth modulating volatiles is widespread among rhizosphere bacteria and strongly depends on culture conditions. Environ. Microbiol. 13: 3047-3058).
La capacidad de las especies silvestres de tomate de producir cantidades significativas de 2-TDC, se ha relacionado con la alta resistencia innata de estas plantas frente al ataque de insectos herbívoros y ácaros (Williams et al. 1980. 2- Tridecanone: A Naturally Occurring Insecticide from the Wild Tomato Lycopersicon hirsutum í.glabratum. Science 207:888- 889; Weston et al. 1989. Trichome secretion composition, trichome densities, and spider mite resistance of 10 accessions of Lycopersicon hirsutum. Journal of American Horticultural Science, 114, 492-498; Chatzivasileiadis and Sabelis (1997) Toxicity of methylketones from tomato trichomes to Tetranychus urticae Koch. Experimental and Applied Acarology, 21, 473-484; Gonc.alves, et al. 1998. Variation of 2-tridecanone level in tomato plant leaflets and resistance to two mite species {Tetranychus sp . ) . Euphytica, 104,33-38) . The ability of wild tomato species to produce significant amounts of 2-TDC has been linked to the high innate resistance of these plants against the attack of herbivorous insects and mites (Williams et al. 1980. 2- Tridecanone: A Naturally Occurring Insecticide from the Wild Tomato Lycopersicon hirsutum í.glabratum. Science 207: 888-889; Weston et al. 1989. Trichome secretion composition, trichome densities, and spider mite resistance of 10 accessions of Lycopersicon hirsutum. Journal of American Horticultural Science, 114, 492-498; Chatzivasileiadis and Sabelis (1997) Toxicity of methylketones from tomato trichomes to Tetranychus urticae Koch. Experimental and Applied Acarology, 21, 473-484; Gonc.alves, et al. 1998. Variation of 2-tridecanone level in tomato plant leaflets and resistance to two mite species {Tetranychus sp.). Euphytica, 104.33-38).
Existen estudios que demuestran la actividad insecticida y acaricióla de la 2-TDC (Antonious et al. 2003. Insecticidal and acaricidal performance of methyl ketones in wild tomato leaves. Bull . Environ . Contam Toxicol. 71:400-407) . Se sabe que la aplicación de esta metilcetona no induce fitotoxicidad cuando es aplicada en spray a concentraciones de 0.44 g por litro de agua (Antonious. 2004. Persistence of 2-tridecanone on the leaves of seven vegetables. Bull . Environ . Contam Toxicol. 73:1086-1093) . La 2-TDC ha sido descrita como repelente de mosquitos y garrapatas (Roe (2004) Method of repelling insects. U.S. Patent Application 20040242703, Kina code A.I. Myers, Bisel, Sibley, & Sajovec, Raleigh, NC . ) . También se ha divulgado el uso de 1 ó más metilcetonas , entre ellas la 2-TDC, para el control de infestaciones por nemátodos en plantas asi como la construcción y empleo de plantas transgénicas y bacterias modificadas genéticamente para ser aplicadas en plantas capaces de producir 2-TDC o una combinación de metilcetonas y compuestos relacionados para el control de ataques por insectos y nemátodos (Bradley et al. 2009, solicitud de patente WO 2009/100433 "Methods and compositions for plant pest control"; Bradley et al. 2011, solicitud de patente WO 2011/100650 "Improved compositions and methods for pathogen control in plants") . There are studies that demonstrate insecticidal activity and 2-TDC strokes (Antonious et al. 2003. Insecticidal and acaricidal performance of methyl ketones in wild tomato leaves. Bull. Environ. Contam Toxicol. 71: 400-407). It is known that the application of this methyl ketone does not induce phytotoxicity when sprayed at concentrations of 0.44 g per liter of water (Antonious. 2004. Persistence of 2-tridecanone on the leaves of seven vegetables. Bull. Environ. Contam Toxicol. 73 : 1086-1093). 2-TDC has been described as a mosquito and tick repellent (Roe (2004) Method of repelling insects. US Patent Application 20040242703, Kina code AI Myers, Bevel, Sibley, & Sajovec, Raleigh, NC.). The use of 1 or more methyl ketones, including 2-TDC, for the control of nematode infestations in plants as well as the construction and use of transgenic plants and genetically modified bacteria to be applied in plants capable of producing 2 has also been disclosed. -TDC or a combination of methyl ketones and related compounds for the control of attacks by insects and nematodes (Bradley et al. 2009, patent application WO 2009/100433 "Methods and compositions for plant pest control"; Bradley et al. 2011, application WO 2011/100650 "Improved compositions and methods for pathogen control in plants").
Sin embargo, aunque la 2-TDC se ha demostrado ser efectiva en el control de pestes (insectos y nemátodos) que atacan a las plantas, nunca ha sido probado su efecto en el control de infecciones bacterianas. Aunque se ha descrito el efecto antimicrobiano frente a ciertas bacterias y hongos de los aceites esenciales de Glossocalyx staudtii , algunos de los cuales contienen un alto porcentaje de 2-TDC, como es el caso del extraído de la raíz de esta planta donde la 2-TDC constituye el 55.2% (Agnaniet et al. 2009. Chemical composition and antimicrobial activity of the essential oils of leaves, roots and bark of Glossocalyx staudtii. Nat. Prod. Commun. 4:1127-1132), nunca se ha demostrado que el efecto bactericida de estos aceites esenciales sea debido a la presencia de la metilcetona; De hecho, los propios autores sugieren que este componente del aceite no es tan eficiente como podría pensarse (página 1130) . Además, existe al menos otra referencia bibliográfica que podría sugerir que la 2-TDC no fuera efectiva frente a infecciones bacterianas, ya que se ha demostrado que no muestra actividad antimicrobiana ni frente a hongos ni frente a bacterias Gram positivas como Staphylococcus r Streptococcus r o Bacillus ni Gram negativas como Pseudomonas r Escherichia r o Proteus (Wood et al. 1995. Volatile ketones from interdigital glands of black-tailed deer, Odocoileus hemionus columbianus. J. Chem Ecol. 21:1401- 1408) . However, although 2-TDC has been shown to be effective in controlling pests (insects and nematodes) that attack plants, its effect on the control of bacterial infections has never been proven. Although the antimicrobial effect against certain bacteria and fungi of the essential oils of Glossocalyx staudtii has been described, some of which contain a high percentage of 2-TDC, as is the case with the extraction of the root of this plant where the 2- TDC constitutes 55.2% (Agnaniet et al. 2009. Chemical composition and antimicrobial activity of the essential oils of leaves, roots and bark of Glossocalyx staudtii. Nat. Prod. Commun. 4: 1127-1132), it has never been shown that Bactericidal effect of these essential oils is due to the presence of methyl ketone; In fact, the authors themselves suggest that this component of the oil is not as efficient as one might think (page 1130). In addition, there is at least one other bibliographic reference that could suggest that 2-TDC was not effective against bacterial infections, since it has been shown that it does not show antimicrobial activity against fungi or against Gram positive bacteria such as Staphylococcus r Streptococcus r or Bacillus ni Gram negatives such as Pseudomonas r Escherichia r or Proteus (Wood et al. 1995. Volatile ketones from interdigital glands of black-tailed deer, Odocoileus hemionus columbianus. J. Chem Ecol. 21: 1401-1408).
En definitiva, las infecciones bacterianas pueden causar enfermedades más o menos graves en plantas y animales, incluyendo al ser humano. La importancia de la prevención, control y en su caso tratamiento de las infecciones causadas por bacterias patógenas en seres humanos es obvia. Igualmente importante es prevenir y controlar las enfermedades causadas por bacterias en animales ya que algunas de estas infecciones pueden generar desde grandes pérdidas en el sector ganadero, a intoxicaciones alimentarias o incluso la transmisión de la enfermedad al hombre. Por otro lado, las enfermedades de plantas causadas por bacterias o bacteriosis son responsables de importantes pérdidas en agricultura. Aunque las bacterias fitopatógenas generalmente no pueden causar enfermedades en animales, en los últimos años se han acumulado las evidencias que indican que frutas, hierbas, hortalizas, y en especial las verduras de hoja verde, son auténticos reservorios de bacterias enteropatógenas como Salmonella entérica o Escherichia coli. El origen de la infección puede ser diverso, siendo el agua de riego, la principal vía de contaminación. Puesto que este tipo de alimentos se suelen consumir crudos o con muy poca elaboración, la presencia en ellos de este tipo de patógenos constituye un riesgo para la salud humana. In short, bacterial infections can cause more or less serious diseases in plants and animals, including humans. The importance of prevention, control and, where appropriate, treatment of infections caused by pathogenic bacteria in humans is obvious. Equally important is to prevent and control the diseases caused by bacteria in animals since some of these infections can generate from large losses in the livestock sector, to food poisoning or even the transmission of the disease to man. On the other hand, plant diseases caused by bacteria or bacteriosis are responsible for significant losses in agriculture. Although phytopathogenic bacteria generally cannot cause disease in animals, in recent years evidence has accumulated that fruits, herbs, vegetables, and especially green leafy vegetables, are authentic reservoirs of enteropathogenic bacteria such as enteric Salmonella or Escherichia coli The origin of the infection can be diverse, with irrigation water being the main route of contamination. Since this type of food is usually consumed raw or with very little processing, the presence in them of this type of pathogens constitutes a risk to human health.
El control de las enfermedades de animales y vegetales causadas por bacterias se ha conseguido fundamentalmente mediante el tratamiento químico con antibióticos. Para la prevención de bacteriosis vegetales, también se usan agentes químicos basados en cobre como el caldo bordelés. El efecto negativo que potencialmente tienen estos compuestos tanto en el medio ambiente como en la salud de animales y humanos, así como el desarrollo de resistencias en bacterias patógenas que hacen muy difícil el tratamiento o en el mejor de los casos lo encarece, hace conveniente la búsqueda de soluciones alternativas más seguras. Se han presentado escasas alternativas hasta la fecha. El caso más llamativo es el de la 2-tridecanona, compuesto producido por variedades silvestres de tomate, lo que les confiere una resistencia innata al ataque por insectos herbívoros y ácaros. Esta observación fue el inicio que llevaría posteriormente a demostrar la actividad insecticida y acaricida de la 2-TDC, y a patentar su uso como i) repelente de mosquitos y garrapatas, y ii) control de infestaciones de plantas por insectos y nemátodos. Sin embargo, nunca ha sido probado su efecto en el control de infecciones bacterianas. En este sentido, la presente invención proporciona un nuevo agente para la prevención y control de infecciones bacterianas que causan enfermedades tanto en plantas como en animales y seres humanos. El compuesto es 2-tridecanona (2-TDC), una metilcetona de larga cadena alifática (Fig. 1), producida de forma natural por plantas, animales y bacterias. De esta forma, la presente invención ofrece una alternativa muy ventajosa que también tiene aplicación en la higiene de instalaciones susceptibles de contaminación por bacterias. The control of animal and plant diseases caused by bacteria has been achieved primarily by chemical treatment with antibiotics. For the prevention of plant bacteriosis, copper-based chemical agents such as Bordeaux broth are also used. The negative effect that these compounds potentially have on both the environment and the health of animals and humans, as well as the development of resistance in pathogenic bacteria that make treatment very difficult or in the best case makes it more expensive, makes it convenient to search for safer alternative solutions. Few alternatives have been presented to date. The most striking case is that of 2-tridecanone, composed of wild tomato varieties, which gives them an innate resistance to attack by herbivorous insects and mites. This observation was the beginning that would lead later to demonstrate the insecticidal and acaricidal activity of 2-TDC, and to patent its use as i) mosquito and tick repellent, and ii) control of plant infestations by insects and nematodes. However, its effect on the control of bacterial infections has never been proven. In this sense, the present invention provides a new agent for the prevention and control of bacterial infections that cause diseases in both plants and animals and humans. The compound is 2-tridecanone (2-TDC), a long-chain aliphatic methyl ketone (Fig. 1), produced naturally by plants, animals and bacteria. Thus, the present invention offers a very advantageous alternative that also has application in the hygiene of facilities susceptible to contamination by bacteria.
Además, este uso de la 2-tridecanona es inesperado y sorprendente, en primer lugar porque existen documentos como el citado en el párrafo anterior, que sugiere un resultado negativo en este tipo de tratamientos con 2-tridecanona. En segundo lugar, como se comentará más adelante, porque el control de las infecciones bacterianas se produce sin efecto bactericida, es decir, sin destruir ni atacar al crecimiento bacteriano, pero sí a su actividad infectiva. Descripción general de la invención In addition, this use of 2-tridecanone is unexpected and surprising, firstly because there are documents such as the one mentioned in the previous paragraph, which suggests a negative result in this type of treatment with 2-tridecanone. Secondly, as will be discussed later, because the control of bacterial infections occurs without bactericidal effect, that is, without destroying or attacking bacterial growth, but with its infective activity. General Description of the Invention
La presente invención se refiere, en un primer objeto, a un método para prevenir y/o controlar infecciones bacterianas en una planta y/o cultivo, caracterizado porque comprende administrar una metilcetona de cadena alifática larga de fórmula general (I) :
Figure imgf000011_0001
The present invention relates, in a first object, to a method for preventing and / or controlling bacterial infections in a plant and / or crop, characterized in that it comprises administering a long aliphatic chain methyl ketone of general formula (I):
Figure imgf000011_0001
(I) (I)
donde R1 representa una cadena alifática C9-C13, es decir formada por un número comprendido entre 9 y 13 átomos de carbono, o lo que es lo mismo R1 representa una cadena CH3(CH2)nCH2 donde n=7-ll, where R 1 represents a C9-C13 aliphatic chain, that is to say formed by a number between 9 and 13 carbon atoms, or what is the same R 1 represents a CH 3 (CH 2 ) nCH 2 chain where n = 7- ll,
como es la 2-tridecanona (2-TDC) . En el ámbito de la presente invención, la acción de "controlar" se entiende como evitar infecciones adicionales a las ya existentes, no habiéndose constatado que el compuesto en cuestión tenga un efecto de tratamiento por el cual se eliminen infecciones ya establecidas. Como se infiere de la definición anterior, el término "cadena alifática larga" se refiere en la presente invención a una cadena formada por un número comprendido entre 9 y 13 átomos de carbono. as is 2-tridecanone (2-TDC). Within the scope of the present invention, the action of "controlling" is understood as avoiding additional infections to those already existing, it being not found that the compound in question has a treatment effect whereby already established infections are eliminated. As inferred from the above definition, the term "long aliphatic chain" refers in the present invention to a chain formed by a number comprised between 9 and 13 carbon atoms.
Un segundo objeto de protección está constituido por un método para prevenir y/o controlar infecciones causadas por bacterias patógenas de animales y humanos que pudieran encontrarse contaminando alimentos instalaciones de producción y tratamiento de alimentos, instalaciones de contención, transporte y cuidado de animales, y en materiales e instalaciones médicos susceptibles de estar contaminados con bacterias patógenas, mediante aplicación de las metilcetonas de larga cadena alifática descritas anteriormente . Un tercer objeto de protección consiste en el uso de las metilcetonas de larga cadena alifática de fórmula general (I) antes definidas, como es la metilcetona 2-tridecanona, en la prevención y/o control de infecciones bacterianas tanto en el campo fitosanitario, como en el campo de la Higiene y la Sanidad de instalaciones, alimentos o en la fabricación de productos consumibles, entre otros usos. Un cuarto objeto de protección se refiere a la metilcetona de larga cadena alifática de fórmula general (I) antes definidas, como es la metilcetona 2-tridecanona, para uso en medicina, y más concretamente de manera particularmente preferida a su uso en la prevención y/o tratamiento de infecciones bacterianas en un sujeto. Cuando en la presente memoria se describe la metilcetona, y más concretamente la 2- tridecanona, para uso en medicina, y realizaciones preferentes de dicha metilcetona, debe entenderse que la invención se refiere o cubre igualmente el uso de la metilcetona en medicina. A second object of protection is constituted by a method to prevent and / or control infections caused by pathogenic bacteria of animals and humans that could be found contaminating food production facilities and food treatment, containment facilities, transport and care of animals, and in Medical materials and facilities likely to be contaminated with pathogenic bacteria, by applying the aliphatic long chain methyl ketones described above. A third object of protection consists in the use of the aliphatic long chain methyl ketones of general formula (I) defined above, such as methyl ketone 2-tridecanone, in the prevention and / or control of bacterial infections both in the phytosanitary field, such as in the field of Hygiene and Health of facilities, food or in the manufacture of consumable products, among other uses. A fourth object of protection refers to the aliphatic long chain methyl ketone of general formula (I) defined above, such as methyl ketone 2-tridecanone, for use in medicine, and more particularly particularly preferably to its use in prevention and / or treatment of bacterial infections in a subject. When methyl ketone is described herein, and more specifically 2-tridecanone, for use in medicine, and preferred embodiments of said methyl ketone, it should be understood that the invention also relates to or covers the use of methyl ketone in medicine.
En la presente memoria debe entenderse que un objeto sobre el que se aplica la 2-tridecanona u otra metilcetona de larga cadena alifática de fórmula general (I) es "susceptible de estar contaminado por bacterias" cuando dicho objeto, sea una planta, un animal, un ser humano, un producto o una instalación presenta riesgo de contagio, por cualquier razón (sensibilidad, exposición...) . Como se deriva de este apartado, la invención se basa en la aplicación/administración del compuesto orgánico natural metilcetona de larga cadena alifática de fórmula general (I), siendo su mejor ejemplo la 2-tridecanona (2-TDC) , a individuos (plantas, animales, humanos), productos o instalaciones con riesgo de contaminación bacteriana que pueda dar lugar al desarrollo de una enfermedad. Con ella se pretende fundamentalmente aminorar los efectos adversos generados en el medioambiente y en la salud animal y humana de los tratamientos clásicos con agentes químicos contaminantes y antibióticos que pueden favorecer la aparición de microorganismos resistentes. De esta forma, la invención trata acerca del uso de la 2-tridecanona u otra metilcetona de larga cadena alifática de fórmula (I) en la prevención y tratamiento de infecciones bacterianas, tanto en plantas, como en animales, seres humanos e incluso instalaciones y alimentos susceptibles de verse afectados por contaminación de bacterias. En la presente memoria se trata cada una de estas aplicaciones de manera separada, en función del objeto de aplicación. It should be understood herein that an object on which 2-tridecanone or another aliphatic long chain methyl ketone of general formula (I) is applied is "susceptible to being contaminated by bacteria" when said object, be it a plant, an animal , a human being, a product or an installation presents a risk of contagion, for any reason (sensitivity, exposure ...). As derived from this section, the invention is based on the application / administration of the natural organic aliphatic long chain methyl ketone compound of general formula (I), with 2-tridecanone (2-TDC) being the best example, to individuals (plants , animals, humans), products or facilities at risk of bacterial contamination that may lead to the development of a disease. With it, it is primarily intended to reduce the adverse effects generated in the environment and in animal and human health of the classic treatments with contaminating chemical agents and antibiotics that can favor the emergence of resistant microorganisms. Thus, the invention is about the use of 2-tridecanone or other aliphatic long chain methyl ketone of formula (I) in the prevention and treatment of bacterial infections, both in plants, as in animals, humans and even facilities and Foods likely to be affected by bacteria contamination. Each of these applications is treated separately here, depending on the application object.
La principal ventaja del uso de metilcetonas de larga cadena alifática definidas por la fórmula (I) es la de ser compuestos naturales producidos por numerosos organismos, entre ellos plantas y animales, de bajo o nulo impacto en el medio ambiente. Hasta el momento no se han descrito efectos nocivos de estos compuestos, en especial de la 2-TDC sobre organismos vivos. Este compuesto se halla disponible en el mercado y no es un producto caro (Alfa Aesar 83.6 euros/100 g) · The main advantage of using aliphatic long chain methyl ketones defined by formula (I) is that they are natural compounds produced by numerous organisms, including plants and animals, of low or no impact on the environment. So far no harmful effects of these compounds have been described, especially 2-TDC on living organisms. This compound is available in the market and is not an expensive product (Alfa Aesar 83.6 euros / 100 g) ·
Además, las metilcetonas descritas en la presente memoria, en concreto la 2-TDC, son biodegradables (existen bacterias capaces de utilizar 2-TDC como fuente de carbono) . Todo ello implica que el uso de los mismos no genera problemas desde el punto de vista medioambiental y está exento de riesgos para la salud humana y animal. Este resultado es de doble interés en el campo de la técnica por las siguientes razones: en primer lugar, es inesperado por cuanto existen documentos en el estado de la técnica que sugieren la inexistencia de un efecto significativo y de interés de las metilcetonas de larga cadena alifática en bacterias y las infecciones que provocan. Así, Wood et al (1995; Volatile ketones from interdigital glands of black- tailed deer, Odocoileus hemionus columbianus . J. Chem Ecol . 21:1401-1408) comprueban que la 2-tridecanona no muestra actividad antimicrobiana ni frente a hongos ni frente a bacterias Gram positivas como Staphylococcus r Streptococcus r o Bacillus ni Gram negativas como Pseudomonas , Escherichia , o Proteus . En segundo lugar, el resultado obtenido con la presente invención es sorprendente, en la medida en que se ha comprobado que el mecanismo por el que la 2-TDC limita la infección bacteriana no se debe a un efecto bactericida (que consiste en la destrucción/muerte de bacterias) . El hecho de que el crecimiento de la bacteria no se vea afectado en presencia de 2-TDC a determinadas concentraciones, compuesto que por el contrario si limita la infección, reduce la presión selectiva y por tanto, la aparición de posibles resistencias, es un resultado totalmente inesperado, sobre todo en vista de lo indicado por otros autores. In addition, the methyl ketones described herein, specifically 2-TDC, are biodegradable (there are bacteria capable of using 2-TDC as a carbon source). All this implies that their use does not generate problems from an environmental point of view and is free of risks to human and animal health. This result is of double interest in the field of technology for the following reasons: first, it is unexpected because there are documents in the state of the art that suggest the absence of a significant and interesting effect of long chain methyl ketones aliphatic in bacteria and the infections they cause. Thus, Wood et al (1995; Volatile ketones from interdigital glands of black-tailed deer, Odocoileus hemionus columbianus. J. Chem Ecol. 21: 1401-1408) prove that 2-tridecanone does not show antimicrobial activity neither against fungi nor against Gram positive bacteria such as Staphylococcus r Streptococcus r or Bacillus nor Gram negative such as Pseudomonas, Escherichia, or Proteus. Secondly, the result obtained with the present invention is surprising, insofar as it has been found that the mechanism by which 2-TDC limits bacterial infection is not due to a bactericidal effect (consisting of destruction / death of bacteria). The fact that the growth of the bacteria is not affected in the presence of 2-TDC at certain concentrations, a compound that, on the contrary, if it limits the infection, reduces the selective pressure and therefore, the appearance of possible resistance, is a result totally unexpected, especially in view of what is indicated by other authors.
Las investigaciones que han conducido a la presente invención han permitido comprobar que efectivamente la adición de una metilcetona de larga cadena alifática de fórmula (I), siendo el mejor ejemplo la 2-TDC, a distintas concentraciones (preferiblemente en el intervalo de 1 μΜ y 10 mM, y más preferentemente dentro del intervalo de 5-500 uM) no afectó al crecimiento de distintas bacterias (tanto bacterias que interaccionan con plantas como Sinorhizobium meliloti (mutualista) y Pseudomonas syringae (patógena) o bacterias patógenas de animales como Salmonella typhimurium) . Sin embargo, en todos los casos ensayados, si que afectó a un comportamiento bacteriano que está muy relacionado con la virulencia de bacterias patógenas: la motilidad swarming, un tipo de translocación bacteriana que ocurre en superficies y que requiere actividad flagelar. Concretamente, la adición de 2-TDC comercial (SIGMA) en concentraciones del orden micromolar indujo motilidad en superficie en bacterias que interaccionan con plantas (como S. meliloti que forma simbiosis fijadora de nitrógeno con plantas de alfalfa (Fig. 2A) , y en la bacteria fitopatógena P. syringae (Fig. 2B) ) , mientras que anuló el movimiento en superficie de una bacteria patógena de animales como S. typhimurium (Fig. 2C) . Resultados similares a los obtenidos con 2-TDC en la motilidad swarming de S. meliloti y de P. syringae se han obtenido con las metilcetonas 2-dodecadona, 2-pentadecanona, y 2-undecanona, resultados que demuestran la potencialidad de estas metilcetonas para los usos descritos en la presente memoria (Fig. 7) . Además, en algunos casos, la adición de 2- TDC no sólo alteró la motilidad swarming sino que además interfirió negativamente con la formación de biofilm (Fig. 3), otro fenómeno multicelular asociado a superficie, que muestra conexión con la motilidad swarming, y que es responsable de la persistencia de algunas infecciones bacterianas. Estos resultados sugieren que la 2-TDC y otras metilcetonas muy similares pueden ser reconocidas como molécula señal en bacterias, interfiriendo con fenotipos como la motilidad y la formación de biofilm que tienen un papel relevante en las interacciones que estos microorganismos establecen con hospedadores eucariotas . The investigations that have led to the present invention have made it possible to verify that indeed the addition of a long-chain aliphatic methyl ketone of formula (I), the best example being 2-TDC, at different concentrations (preferably in the range of 1 μΜ and 10 mM, and more preferably within the range of 5-500 uM) did not affect the growth of different bacteria (both bacteria that interact with plants such as Sinorhizobium meliloti (mutual)) and Pseudomonas syringae (pathogenic) or pathogenic bacteria of animals such as Salmonella typhimurium) . However, in all the cases tested, it did affect a bacterial behavior that is closely related to the virulence of pathogenic bacteria: swarming motility, a type of bacterial translocation that occurs on surfaces and that requires flagellar activity. Specifically, the addition of commercial 2-TDC (SIGMA) in concentrations of the micromolar order induced surface motility in bacteria that interact with plants (such as S. meliloti that forms nitrogen-fixing symbiosis with alfalfa plants (Fig. 2A), and in the phytopathogenic bacterium P. syringae (Fig. 2B)), while canceling the surface movement of a pathogenic bacterium of animals such as S. typhimurium (Fig. 2C). Similar results to those obtained with 2-TDC in the Swarming motility of S. meliloti and P. syringae have been obtained with methyl ketones 2-dodecadone, 2-pentadecanone, and 2-undecanone, results that demonstrate the potential of these methyl ketones for the uses described herein (Fig. 7 ). In addition, in some cases, the addition of 2- TDC not only altered swarming motility but also negatively interfered with the formation of biofilm (Fig. 3), another multicellular surface-associated phenomenon, showing connection with swarming motility, and which is responsible for the persistence of some bacterial infections. These results suggest that 2-TDC and other very similar methyl ketones can be recognized as a signal molecule in bacteria, interfering with phenotypes such as motility and biofilm formation that have a relevant role in the interactions that these microorganisms establish with eukaryotic hosts.
Descripción detallada de la invención Detailed description of the invention
De manera preferida, la cadena alifática larga de la metilcetona de fórmula general (I) es una cadena alifática lineal. El término "cadena lineal" se refiere en la presente invención a una cadena formada por un número comprendido entre 9 y 13 átomos de carbono unidos entre si mediante enlaces covalentes C-C, complementada su estructura con uniones a hidrógenos.  Preferably, the long aliphatic methyl ketone chain of general formula (I) is a linear aliphatic chain. The term "linear chain" refers in the present invention to a chain formed by a number comprised between 9 and 13 carbon atoms bonded together by C-C covalent bonds, complemented its structure with hydrogen bonds.
De manera más preferida, la cadena alifática lineal es saturada. El término "cadena saturada" se refiere en la presente invención a una cadena carbonada en la que no hay ningún doble o triple enlace. More preferably, the linear aliphatic chain is saturated. The term "saturated chain" refers in the present invention to a carbon chain in which there is no double or triple bond.
Preferiblemente, la metilcetona de larga cadena alifática de fórmula general (I) es seleccionada dentro del grupo compuesto por 2-tridecanona, 2-dodecadona, 2-pentadecanona y 2-undecanona. En la realización más preferida, la metilcetona es 2-tridecanona. Preferably, the aliphatic long chain methyl ketone of general formula (I) is selected from the group consisting of 2-tridecanone, 2-dodecadone, 2-pentadecanone and 2-undecanone. In the most preferred embodiment, the methyl ketone is 2-tridecanone.
La utilización de la invención como producto fitosanitario tiene especial interés, aunque no es limitativo de la invención, en la aplicación de las metilcetonas de larga cadena alifática definidas en la presente memoria, como es la 2-TDC, en plantas o cultivos que no producen cantidades significativas de estos compuestos durante épocas de riesgo, para protegerlas de infecciones bacterianas que potencialmente pueden causarles daño o enfermedad. Puesto que son pocas las plantas en las que se ha descrito la producción significativa de estos compuestos, la invención es potencialmente útil para todo tipo de plantas. The use of the invention as a phytosanitary product It is of special interest, although not limited to the invention, in the application of the aliphatic long chain methyl ketones defined herein, such as 2-TDC, in plants or crops that do not produce significant amounts of these compounds during times of risk, to protect them from bacterial infections that can potentially cause them harm or disease. Since there are few plants in which the significant production of these compounds has been described, the invention is potentially useful for all types of plants.
La metilcetona descrita puede administrarse en forma diluida en un liquido. Preferentemente, se administra en forma de solución. Más preferentemente todavía, la metilcetona de larga cadena alifática de fórmula general (I) está diluida en la solución en una concentración comprendida entre 1 μΜ y 10 mM, incluidos ambos límites, y en el caso más preferido está comprendida entre 5 μΜ y 500 μΜ, incluidos ambos límites. De manera preferida también, la solución que contiene el compuesto en cuestión es una solución etanólica. Dicha solución etanólica es preferentemente etanólica 0.1% (v/v, etanol/agua) , de tal forma que 1 L de solución conteniendo el compuesto activo metilcetona a una concentración de 50 μΜ contendría 999 mi de agua, 1 mi de etanol y: 10 mg de 2-TDC previamente disuelta en el etanol, ú 8.5 mg de 2-undecanona; o 9.2 mg para la 2-dodecanona; y 11.32 mg para la 2- pentadecanona . The methyl ketone described can be administered in diluted form in a liquid. Preferably, it is administered as a solution. More preferably still, the aliphatic long chain methyl ketone of general formula (I) is diluted in the solution in a concentration between 1 μΜ and 10 mM, including both limits, and in the most preferred case is between 5 μΜ and 500 μΜ , including both limits. Also preferably, the solution containing the compound in question is an ethanolic solution. Said ethanolic solution is preferably 0.1% ethanol (v / v, ethanol / water), such that 1 L of solution containing the active compound methyl ketone at a concentration of 50 μΜ would contain 999 ml of water, 1 ml of ethanol and: 2-TDC mg previously dissolved in ethanol, or 8.5 mg of 2-undecanone; or 9.2 mg for 2-dodecanone; and 11.32 mg for 2- pentadecanone.
En una realización preferida, la metilcetona de larga cadena alifática de fórmula (I), como puede ser la 2-tridecanona, se aplica mediante pulverización (spray) de la parte aérea de la planta con la solución, que es preferentemente etanólica 0.1% (v/v, etanol/agua), conteniendo concentraciones efectivas del compuesto. Se pulveriza intentando que la superficie a tratar quede homogéneamente humedecida. In a preferred embodiment, the aliphatic long chain methyl ketone of formula (I), such as 2-tridecanone, is applied by spraying (spray) the aerial part of the plant with the solution, which is preferably 0.1% ethanolic ( v / v, ethanol / water), containing effective concentrations of the compound. It is sprayed trying to make the surface to be treated homogeneously moistened.
En otra realización preferida, la solución se inyecta directamente en el tallo de la planta, mediante métodos convencionales . In another preferred embodiment, the solution is injected directly into the plant stem, by methods conventional.
En otra realización preferida, la invención implica la administración directa de la solución de la metilcetona definida anteriormente al suelo o a otro medio de crecimiento de la planta. La administración puede ser indirectamente a través del agua de riego o de una solución nutritiva para la planta, o por inmersión del sistema radicular o de la totalidad de la planta (o de semillas) en la solución con 2- tridecanona u otra metilcetona de larga cadena alifática de fórmula general (I) . La solución se prepararía como se ha indicado anteriormente, pudiendo sustituir el agua por solución nutritiva de crecimiento para plantas. En cualquiera de los casos comentados, las aplicaciones del compuesto sobre la planta o el suelo de cultivo u otro medio de crecimiento se realizarán en concentraciones no fitotóxicas, preferiblemente en las épocas del año de máximo riesgo, y pudiéndose realizar varias aplicaciones espaciadas en el tiempo. La concentración fitotóxica a emplear va a depender del tipo de planta y del modo de administración, ya que por ejemplo se ha comprobado que a concentraciones similares, en forma hidropónica el efecto fitotóxico es más pronunciado que en la pulverización aérea, siempre dentro de los intervalos definidos en esta memoria. In another preferred embodiment, the invention involves the direct administration of the methyl ketone solution defined above to the soil or other plant growth medium. Administration can be indirectly through irrigation water or a nutrient solution for the plant, or by immersion of the root system or of the entire plant (or seeds) in the solution with 2- tridecanone or other methyl ketone long aliphatic chain of general formula (I). The solution would be prepared as indicated above, being able to replace the water with nutrient solution for plant growth. In any of the cases mentioned, the applications of the compound on the plant or the cultivation soil or other growth medium will be carried out in non-phytotoxic concentrations, preferably at times of the year of maximum risk, and several applications can be made spaced over time . The phytotoxic concentration to be used will depend on the type of plant and the mode of administration, since for example it has been found that at similar concentrations, in a hydroponic way the phytotoxic effect is more pronounced than in aerial spraying, always within the intervals defined in this memory.
De esta forma, la máxima efectividad de la metilcetona de fórmula general (I) se obtuvo utilizando concentraciones entre 1 μΜ y 10 mM, incluidos ambos límites, aunque obviamente la concentración óptima del compuesto para ejercer su efecto protector dependió del tipo de planta, fase de desarrollo de la misma, así como de la frecuencia y forma de aplicación. Así, se ha demostrado con la presente invención el efecto de la metilcetona de fórmula general (I) en la limitación de infecciones bacterianas a concentraciones inferiores (mínimo 4.4 veces inferior) a las descritas como no fitotóxicas tras su aplicación en spray, lo que supone una gran ventaja. Asimismo, la 2-TDC u otra metilcetona de fórmula general (I) puede aplicarse sola o se puede mezclar con otros aditivos conocidos y empleados comúnmente en el campo de la Agricultura, por ejemplo fertilizantes orgánicos y/o inorgánicos, insecticidas, nematicidas, fungicidas, bactericidas y herbicidas, y cualquier combinación de los mismos. La metilcetona puede ser aplicada a las plantas antes, después o simultáneamente a los mencionados pesticidas, herbicidas o similares. Thus, the maximum effectiveness of the methyl ketone of general formula (I) was obtained using concentrations between 1 μΜ and 10 mM, including both limits, although obviously the optimum concentration of the compound to exert its protective effect depended on the type of plant, phase of its development, as well as the frequency and form of application. Thus, the effect of methyl ketone of general formula (I) on the limitation of bacterial infections at lower concentrations (minimum 4.4 times lower) than those described as non-phytotoxic after spray application has been demonstrated, which means a big advantage. Also, 2-TDC or other methyl ketone of general formula (I) can be applied alone or mixed with other additives known and commonly used in the field of Agriculture, for example organic and / or inorganic fertilizers, insecticides, nematicides, fungicides , bactericides and herbicides, and any combination thereof. Methyl ketone can be applied to plants before, after or simultaneously to the mentioned pesticides, herbicides or the like.
En lo que respecta al método de prevención y/o control de infecciones bacterianas mediante 2-tridecanona u otra metilcetona de fórmula general (I) con fines higiénicos y sanitarios dentro del campo de la higiene y la alimentación, cabe indicar que las formas de administración y concentraciones descritas para el uso fitosanitario se aplican del mismo modo aquí. Asi, también en este caso la efectividad de la metilcetona, concretamente de la 2-TDC, se observó utilizando concentraciones entre 1 μΜ y 10 mM incluidos ambos limites en una solución, preferentemente etanólica, y más preferentemente en una concentración comprendida entre 5 μΜ y 500 μΜ, incluidos ambos limites. Dicha solución etanólica es preferentemente etanólica 0.1% (v/v, etanol/agua) . With regard to the method of prevention and / or control of bacterial infections by means of 2-tridecanone or another methyl ketone of general formula (I) for hygienic and sanitary purposes within the field of hygiene and food, it should be noted that the forms of administration and concentrations described for phytosanitary use are applied in the same way here. Thus, also in this case the effectiveness of methyl ketone, specifically 2-TDC, was observed using concentrations between 1 μΜ and 10 mM including both limits in a solution, preferably ethanol, and more preferably in a concentration between 5 μΜ and 500 μΜ, including both limits. Said ethanolic solution is preferably 0.1% ethanol (v / v, ethanol / water).
El producto a tratar puede ser de muy diversa índole: alimentos, material quirúrgico... o puede ser una instalación susceptible de contaminación por bacterias (instalación de producción y tratamiento de alimentos, de contención, transporte y cuidado de animales, hospitales y centros sanitarios, cocinas, sistemas o torres de refrigeración, humidificadores...) . Este método se dirige sobre todo, aunque no limitativamente, a productos del sector hortofruticola, con objeto de interferir con los mecanismos de infección de potenciales patógenos que estuvieran contaminando el material vegetal comestible. Sin embargo, este método puede emplearse también en otros productos susceptibles de estar contaminados, como son los de origen animal: cáscara de huevos... The product to be treated can be of a very diverse nature: food, surgical equipment ... or it can be an installation susceptible to contamination by bacteria (food production and treatment, containment, transport and care of animals, hospitals and health centers , kitchens, cooling systems or towers, humidifiers ...). This method is aimed primarily, but not limited to, products from the fruit and vegetable sector, in order to interfere with the mechanisms of infection of potential pathogens that were contaminating the edible plant material. However, this method can also be used in other products that may be contaminated, such as those of animal origin: eggshell ...
Cuando se trata de un producto alimentario, como son los productos hortofruticolas , la administración del compuesto puede realizarse tras su recolección, y siempre en concentraciones no tóxicas para el consumo humano. En otra realización preferida, el método se lleva a cabo mediante la inmersión de la totalidad del producto en una solución del compuesto activo tal como se describe en esta memoria, en cualquiera de sus variantes. When it is a food product, such as fruit and vegetable products, the administration of the compound can be done after its collection, and always in concentrations not toxic to human consumption. In another preferred embodiment, the method is carried out by immersing the entire product in a solution of the active compound as described herein, in any of its variants.
Como en el método anterior, la forma recomendada y más preferible incluye la pulverización del producto destinado a consumo o de la instalación pertinente con una solución etanólica conteniendo concentraciones entre 1 μΜ y 10 mM o más especificas, tal cual se han descrito en la presente memoria . En otra realización preferida, para administrar la solución que contiene la 2-tridecanona u otra metilcetona de fórmula general (I) se emplea el sistema de aire acondicionado y/o el sistema de refrigeración de la instalación a tratar. Como se ha afirmado en el apartado anterior, la presente invención se dirige asimismo al uso de la metilcetona de fórmula general (I), como es por ejemplo la 2-tridecanona, para prevenir y/o tratar infecciones bacterianas con fines fitosanitarios , es decir en plantas y/o cultivos. Preferentemente, el uso de la 2-tridecanona u otra metilcetona de larga cadena alifática está dirigido a la prevención y/o control de infecciones frente a patovares de Pseudomonas syringae, P. savastanoi , Clavibacter michiganensis r Xanthomonas campestris, X. citri, Xylella fastidiosa, Ralstonia solanacearum, Agrobacterium turnefaciens o Erwinia amylovora. También está contemplado aquí el uso de la 2-tridecanona u otra metilcetona de fórmula general (I) para prevenir y/o controlar infecciones causadas por bacterias patógenas de animales y humanos que pudieran encontrarse contaminando productos alimentarios y/o instalaciones de producción de dichos alimentos. Más específicamente, estos productos pueden ser de origen vegetal, como son los hortofrutícolas , o de origen animal, como son los huevos. El uso de la metilcetona de fórmula general (I), como es la 2-tridecanona, cubre asimismo la prevención de infecciones causadas por bacterias que se pudieran encontrar contaminando instalaciones de contención y transporte de animales, al igual que en instalaciones de uso médico y hospitalario y al material que en ellas se utiliza (por ejemplo, material quirúrgico, catéteres...) o en otros espacios susceptibles de contaminación por bacterias, como son las cocinas. As in the previous method, the recommended and most preferable form includes spraying the product intended for consumption or the relevant installation with an ethanolic solution containing concentrations between 1 μΜ and 10 mM or more specific, as described herein. . In another preferred embodiment, the air conditioning system and / or the cooling system of the installation to be treated is used to administer the solution containing the 2-tridecanone or other methyl ketone of the general formula (I). As stated in the previous section, the present invention is also directed to the use of methyl ketone of general formula (I), such as 2-tridecanone, for preventing and / or treating bacterial infections for phytosanitary purposes, that is in plants and / or crops. Preferably, the use of 2-tridecanone or another aliphatic long-chain methyl ketone is directed to the prevention and / or control of infections against Pvaudomonas syringae, P. savastanoi, Clavibacter michiganensis r Xanthomonas campestris, X. citri, Xylella fastidiosa , Ralstonia solanacearum, Agrobacterium turnefaciens or Erwinia amylovora. Also contemplated here is the use of 2-tridecanone or other methyl ketone of general formula (I) to prevent and / or control infections caused by pathogenic bacteria of animals and humans that could be found contaminating food products and / or facilities for producing said foods. . More specifically, these products may be of vegetable origin, such as fruit and vegetable products, or of animal origin, such as eggs. The use of methyl ketone of general formula (I), such as 2-tridecanone, also covers the prevention of infections caused by bacteria that could be found contaminating animal containment and transport facilities, as well as medical facilities and hospital and the material used in them (for example, surgical material, catheters ...) or in other areas susceptible to contamination by bacteria, such as kitchens.
Otro uso previsto para la metilcetona de fórmula general (I) es para la prevención de biofilms en superficies, mediante administración sobre dicha superficie de un material. Another intended use for methyl ketone of general formula (I) is for the prevention of surface biofilms, by administration on said surface of a material.
Constituye otro objeto de la presente invención el uso de la 2-tridecanona u otra metilcetona de fórmula (I) como aditivo frente a infecciones bacterianas en productos de higiene oral (dentífricos, colutorios) o de higiene corporal (jabón de manos) . Another object of the present invention is the use of 2-tridecanone or another methyl ketone of formula (I) as an additive against bacterial infections in oral hygiene products (dentifrices, mouthwashes) or body hygiene (hand soap).
Respecto a la metilcetona de fórmula (I) para uso en medicina (o lo que es lo mismo, el uso de la metilcetona de larga cadena alifática de fórmula (I) para tal fin), debe señalarse que el sujeto susceptible de estar contaminado por bacterias puede ser un ser humano o un animal. La 2-tridecanona u otra metilcetona de larga cadena alifática se administra preferentemente en forma de solución, siendo ésta más preferentemente una solución etanólica. De manera preferida, la metilcetona de fórmula (I) está contenida en la solución en una concentración comprendida entre 1 μΜ y 10 mM, incluidos ambos limites, estando más preferiblemente comprendida entre 5 μΜ y 500 μΜ, incluidos ambos limites. Dicha solución etanólica es preferentemente etanólica 0.1% (v/v, etanol/agua) . With respect to the methyl ketone of formula (I) for use in medicine (or what is the same, the use of the aliphatic long chain methyl ketone of formula (I) for this purpose), it should be noted that the subject susceptible to being contaminated by Bacteria can be a human being or an animal. The 2-tridecanone or other aliphatic long chain methyl ketone is preferably administered in the form of a solution, this being more preferably an ethanolic solution. Preferably, the methyl ketone of formula (I) is contained in the solution in a concentration between 1 μΜ and 10 mM, including both limits, being more preferably between 5 μΜ and 500 μΜ, including both limits. Said ethanolic solution is preferably 0.1% ethanol (v / v, ethanol / water).
Preferentemente, la metilcetona de fórmula general (I) , especialmente la 2-tridecanona, se administra frente a Salmonella typhimurium, Escherichia coli enteropatógenas , Proteus mirabilis r Pseudomonas aeruginosa , Legionella pneumophila . Preferably, the methyl ketone of general formula (I), especially 2-tridecanone, is administered against Salmonella typhimurium, enteropathogenic Escherichia coli, Proteus mirabilis r Pseudomonas aeruginosa, Legionella pneumophila.
De este uso de la 2-tridecanona u otra metilcetona de fórmula general (I) en medicina debe entenderse que la presente invención cubre asimismo: From this use of 2-tridecanone or another methyl ketone of general formula (I) in medicine it should be understood that the present invention also covers:
El uso de la metilcetona de fórmula (I) en la preparación de una composición farmacéutica o un medicamento para medicina, y más preferentemente para la prevención y/o control de infecciones bacterianas; y  The use of the methyl ketone of formula (I) in the preparation of a pharmaceutical composition or a medicine for medicine, and more preferably for the prevention and / or control of bacterial infections; Y
- un método de prevención y/o control de infecciones bacterianas en un sujeto mediante administración de dicha metilcetona de larga cadena alifática de fórmula (I) . Dicha administración puede realizarse por ejemplo por aplicación tópica de heridas abiertas, por vía oral (para evitar infecciones gastrointestinales) o mediante dispositivos de inhalación (evitar infecciones respiratorias), aunque se puede realizar mediante cualquier método conocido y habitual en el campo para este tipo de compuestos. La administración se realiza preferentemente en las cantidades y formatos antes comentados: en solución que es preferiblemente etanólica, a una concentración comprendida entre 1 μΜ y 10 mM, incluidos ambos limites, más preferentemente comprendida entre 5 μΜ y 500 uM, incluidos ambos limites, etc.  - a method of prevention and / or control of bacterial infections in a subject by administration of said aliphatic long chain methyl ketone of formula (I). Such administration can be performed for example by topical application of open wounds, orally (to avoid gastrointestinal infections) or by inhalation devices (avoid respiratory infections), although it can be performed by any known and customary method in the field for this type of compounds. Administration is preferably carried out in the amounts and formats mentioned above: in a solution that is preferably ethanolic, at a concentration between 1 μΜ and 10 mM, including both limits, more preferably between 5 μΜ and 500 uM, including both limits, etc. .
Descripción de las figuras Description of the figures
Figura 1.- Estructura química de la metilcetona, 2- tridecanona (2-TDC) . Figure 1.- Chemical structure of methyl ketone, 2- tridecanone (2-TDC).
Figura 2.- Efecto de la 2-TDC sobre la motilidad en superficie de bacterias que causan infecciones en plantas y animales: Sinorhizobium meliloti, cepas GR4 y GR4fadD; Pseudomonas syringae pv. syringae (Pss) cepa BTlll y P. syringae pv. tomato (Pst) cepa DC3000, y Salmonella typhimurium cepas LT2 y 4155. En todos los casos se muestra el comportamiento de cada bacteria sin tratamiento (M) , en presencia de 20 i de etanol (M + E) , o en presencia de 20 i de una solución etanólica de 2-TDC (M + T) . Se indica la concentración usada en cada caso. Figure 2.- Effect of 2-TDC on the surface motility of bacteria that cause infections in plants and animals: Sinorhizobium meliloti, strains GR4 and GR4fadD; Pseudomonas syringae pv. syringae (Pss) strain BTlll and P. syringae pv. tomato (Pst) strain DC3000, and Salmonella typhimurium strains LT2 and 4155. In all cases the behavior of each bacterium without treatment (M) is shown, in the presence of 20 i of ethanol (M + E), or in the presence of 20 i of an ethanolic solution of 2-TDC (M + T). The concentration used in each case is indicated.
Figura 3.- Efecto de la 2-TDC sobre la capacidad de formación de biofilm de P. syringae pv. syringae BTlll. El biofilm formado en la superficie de un tubo de vidrio tras crecimiento en medio conteniendo sólo etanol (M+E) o medio conteniendo 2-TDC (M+T) a una concentración final de 50μΜ, se detectó mediante tinción con cristal violeta. Figure 3.- Effect of 2-TDC on the biofilm formation capacity of P. syringae pv. syringae BTlll. The biofilm formed on the surface of a glass tube after growth in medium containing only ethanol (M + E) or medium containing 2-TDC (M + T) at a final concentration of 50μΜ, was detected by staining with violet crystal.
Figura 4.- Efecto protector de la 2-TDC en el desarrollo de la mancha negra del tomate. Desarrollo de necrosis en foliólos de plantas de tomate tratadas con las mezclas control C+Mb y E+ Eb, y tratadas con 2 concentraciones distintas de 2-TDC (T+MTlb y T+MT10b) . Figure 4.- Protective effect of 2-TDC on the development of the black spot of tomato. Development of leaf necrosis of tomato plants treated with the control mixtures C + Mb and E + Eb, and treated with 2 different concentrations of 2-TDC (T + MTlb and T + MT10b).
Figura 5.- Efecto del tratamiento de plantas de tomate con 2- TDC sobre la supervivencia a lo largo del tiempo de la bacteria P. syringae pv tomato DC3000 en tejido foliar (expresada como unidades formadoras (cfu) de colonia por cm2) . Los símbolos representan supervivencia en plantas tratadas con C+Mb (círculo) , E+Mb (rombo) , T+MTlb (cuadrado) , o T+MT10b (triángulo) . Figura 6.- Efecto inhibidor de la 2-TDC en la formación de nodulos en plantas de alfalfa por la bacteria Sinorhizobium meliloti, cepa GR4. Figura 7.- Efecto causado por distintas metilcetonas en la motilidad en superficie de Sinorhizobium meliloti GR4 y Pseudomonas syringae pv syringae BT111. En la gráfica se muestra el halo medio de dispersión en superficie de Sm GR4 (barras grises) y Pss BT111 (barras negras) tras 24 horas de incubación en ausencia de metilcetonas (control), en presencia de etanol (E) , o en presencia de 2-undecanona (2- UDC) , 2-dodecanona (2-DDC) , 2-tridecanona (2-TDC) o 2- pentadecanona (2-PDC) . Las barras de error representar el error estándar y letras distintas indican diferencias estadísticamente significativas según un test de ANOVA (P< 0.05) . Figure 5.- Effect of the treatment of tomato plants with 2- TDC on the survival over time of the P. syringae pv tomato DC3000 bacteria in leaf tissue (expressed as colony forming units (cfu) per cm 2 ). The symbols represent survival in plants treated with C + Mb (circle), E + Mb (rhombus), T + MTlb (square), or T + MT10b (triangle). Figure 6.- Inhibitory effect of 2-TDC on nodule formation in alfalfa plants by Sinorhizobium meliloti bacteria, strain GR4. Figure 7.- Effect caused by different methyl ketones on the surface motility of Sinorhizobium meliloti GR4 and Pseudomonas syringae pv syringae BT111. The graph shows the average surface dispersion halo of Sm GR4 (gray bars) and Pss BT111 (black bars) after 24 hours of incubation in the absence of methyl ketones (control), in the presence of ethanol (E), or in the presence of 2-undecanone (2- UDC), 2-dodecanone (2-DDC), 2-tridecanone (2-TDC) or 2- pentadecanone (2-PDC). The error bars represent the standard error and different letters indicate statistically significant differences according to an ANOVA test (P <0.05).
Ejemplos Examples
Ejemplo 1. Eficacia protectora de la aplicación de 2-TDC en la aparición de la mancha negra del tomate causada por la bacteria fitopatógena Pseudomonas syringae pv. tomato DC3000. Como material vegetal se empleó tomate {Solanum lycopersicum "Moneymaker" ) . Las semillas se germinaron y crecieron en semilleros con turba composana en una cámara de crecimiento bajo condiciones controladas de luz, Ta y humedad durante 3 semanas. Posteriormente se transplantaron individualmente en macetas de plástico de 14 cm de diámetro y 13 cm de altura, rellenas de turba, donde se mantuvieron 2 semanas más, antes de proceder a la infección con la bacteria. Example 1. Protective efficacy of the application of 2-TDC in the appearance of the black spot of tomato caused by the phytopathogenic bacterium Pseudomonas syringae pv. tomato DC3000. Tomato {Solanum lycopersicum "Moneymaker") was used as plant material. The seeds germinated and grew in seedbeds with composted peat in a growth chamber under controlled conditions of light, T a and humidity for 3 weeks. Subsequently, they were individually transplanted in plastic pots 14 cm in diameter and 13 cm high, stuffed with peat, where they remained 2 more weeks, before proceeding to infection with the bacteria.
Como bacteria fitopatógena se utilizó la cepa DC3000 de Pseudomonas syringae pv. tomato (Pst) . La bacteria se creció a 28°C en medio LB sólido (triptona 1%, extracto de levadura 0.5%, NaCl 0.5%, agar bacteriológico 1.5%), adicionado de rifampicina (Rif) (10 mg/L) . A partir de estas placas, se preparó una suspensión bacteriana en una solución de 10 mM MgCl2 resuspendiendo masa bacteriana hasta alcanzar una densidad óptica (DC>6oonm) de 0.3-0.4 (corresponde aproximadamente a 108 unidades formadoras de colonia (UFC) /mi) . El tratamiento químico con 2-TDC se realizó en 2 etapas: i) Adición de 40 mg de 2-TDC (equivale a unos 26 kg del compuesto/Hectárea) al sustrato (turba) de cada maceta, 24 horas antes de la aplicación del patógeno y ii) aplicación foliar mediante pulverización de dos concentraciones distintas del compuesto (50iM y 5001M) en el mismo momento de aplicación de la bacteria patógena. Se ha comprobado que estas concentraciones de 2-TDC no generan efectos adversos apreciables en el crecimiento bacteriano en cultivo puro. Tampoco se han observado efectos nocivos en el desarrollo de la planta. As a phytopathogenic bacterium, the strain DC3000 of Pseudomonas syringae pv. tomato (Pst). The bacterium was grown at 28 ° C in solid LB medium (1% tryptone, 0.5% yeast extract, 0.5% NaCl, 1.5% bacteriological agar), added rifampin (Rif) (10 mg / L). From these plates, a bacterial suspension was prepared in a solution of 10 mM MgCl 2 resuspending bacterial mass until reaching an optical density (DC> 6oonm) of 0.3-0.4 (corresponds to approximately 10 8 colony forming units (CFU) / me) . The chemical treatment with 2-TDC was carried out in 2 stages: i) Addition of 40 mg of 2-TDC (equivalent to about 26 kg of the compound / Hectare) to the substrate (peat) of each pot, 24 hours before the application of the pathogen and ii) foliar application by spraying two different concentrations of the compound (50iM and 5001M) at the same time of application of the pathogenic bacteria. It has been proven that these concentrations of 2-TDC do not generate appreciable adverse effects on bacterial growth in pure culture. Nor have harmful effects been observed in the development of the plant.
Para la aplicación al sustrato se prepararon las siguientes soluciones: The following solutions were prepared for application to the substrate:
-Solución T: solución conteniendo 2-TDC preparada como se describe: 40 mg del compuesto se disolvieron en 1 mi de etanol (EtOH) . Una vez conseguida la disolución, la mezcla se añadió a 24 mi de ¾0. -T-solution: solution containing 2-TDC prepared as described: 40 mg of the compound was dissolved in 1 ml of ethanol (EtOH). Once the solution was achieved, the mixture was added to 24 ml of ¾0.
-Solución E, solución control conteniendo EtOH en la misma concentración en la que se encuentra en Sol. T (EtOH al 4% (v/v) ) , y preparada añadiendo 1 mi de EtOH en 24 mi de ¾0. -Solución C, control de riego consistente en 25 mi de ¾0.  - Solution E, control solution containing EtOH in the same concentration as in Sol. T (4% EtOH (v / v)), and prepared by adding 1 ml of EtOH in 24 ml of ¾0. -Solution C, irrigation control consisting of 25 ml of ¾0.
Las macetas se regaron con 25 mi de solución T, E o C que se aplicó alrededor del tallo de la planta. Inmediatamente después, se aplicaron 25 mi adicionales de agua estéril para permitir una buena penetración de los tratamientos en el sustrato. The pots were watered with 25 ml of solution T, E or C that was applied around the plant stem. Immediately afterwards, an additional 25 ml of sterile water was applied to allow a good penetration of the treatments in the substrate.
En todos los casos, el riego se realizó 24 horas antes de la aplicación del fitopatógeno . Para la aplicación foliar, se prepararon las siguientes mezclas : In all cases, irrigation was carried out 24 hours before the application of the phytopathogen. For foliar application, the following mixtures were prepared:
-Mezcla M: 40 mi de una solución de MgCl2 10 mM -Mezcla ME: 40 mi de mezcla M conteniendo 40 μΐ de etanol. -Mezcla MT1: 40 mi de mezcla M conteniendo 40 μΐ de una solución madre de 2-TDC 50 mM (preparada disolviendo 10 mg de 2-TDC por mi de EtOH) . -Mix M: 40 ml of a 10 mM MgCl 2 solution -Me mix: 40 ml of M mixture containing 40 μΐ of ethanol. - MT1 Mix: 40 ml of mixture M containing 40 μΐ of a stock solution of 50 mM 2-TDC (prepared by dissolving 10 mg of 2-TDC per ml of EtOH).
-Mezcla MT10: 40 mi de mezcla M conteniendo 40 μΐ de una solución madre de 2-TDC 500 mM (preparada disolviendo 100 mg de 2-TDC por mi de EtOH) . -MT10 Mix: 40 ml of M mixture containing 40 μΐ of a stock solution of 500 mM 2-TDC (prepared by dissolving 100 mg of 2-TDC per ml of EtOH).
-Mezcla Mb : 40 mi de una solución de MgCl2 10 mM conteniendo la bacteria Pst DC3000 (108 UFC/ml) preparada como se ha indicado anteriormente. -Mb mix: 40 ml of a 10 mM MgCl 2 solution containing the Pst DC3000 bacterium (10 8 CFU / ml) prepared as indicated above.
-Mezcla MEb : 40 mi de mezcla Mb conteniendo 40 μΐ de etanol. -Mezcla MTlb: 40 mi de mezcla Mb conteniendo 40 μΐ de una solución madre de 2-TDC 50 mM (preparada disolviendo 10 mg de 2-TDC por mi de EtOH) .  -Meb mix: 40 ml of Mb mixture containing 40 μΐ of ethanol. - MTlb Mix: 40 ml of Mb mixture containing 40 μΐ of a 50 mM 2-TDC stock solution (prepared by dissolving 10 mg of 2-TDC per ml of EtOH).
-Mezcla MTlOb: 40 mi de mezcla Mb conteniendo 40 μΐ de una solución madre de 2-TDC 500 mM (preparada disolviendo 100 mg de 2-TDC por mi de EtOH) . - MTlOb Mix: 40 ml of Mb mixture containing 40 μΐ of a stock solution of 500 mM 2-TDC (prepared by dissolving 100 mg of 2-TDC per ml of EtOH).
En este ejemplo se utilizaron 20 macetas que se sometieron a los siguientes tratamientos: In this example, 20 pots were used that underwent the following treatments:
24 horas antes de la pulverización de la parte aérea, se procedió al riego del sustrato con Sol. T (10 macetas), Sol. E (5 macetas) y Sol. C (5 macetas) . 24 hours before spraying the aerial part, the substrate was irrigated with Sol. T (10 pots), Sol. E (5 pots) and Sol. C (5 pots).
Antes de llevar a cabo la pulverización de la parte aérea con las distintas mezclas, todas las hojas de todas las macetas se pulverizaron con agua para favorecer la apertura de estomas. La pulverización de cada una de las mezclas se realizó por el haz y envés de 5 foliólos de 2 hojas de cada planta, previamente seleccionadas y debidamente marcadas. Before spraying the aerial part with the different mixtures, all the leaves of all the pots were sprayed with water to favor the opening of stomata. The pulverization of each of the mixtures was carried out by the beam and then 5 leaflets of 2 leaves of each plant, previously selected and duly marked.
De las 10 macetas regadas con Sol. T, se pulverizó con: mezcla MT1 control (1 planta), mezcla MT10 control (1), mezcla MTlb (4) y mezcla MTlOb (4) Of the 10 pots irrigated with Sol. T, it was sprayed with: MT1 control mix (1 plant), MT10 control mix (1), MTlb mix (4) and MTlOb mix (4)
De las 5 macetas regadas con Sol. E, se pulverizó con: mezcla ME control (1 planta), y mezcla MEb (4) . De las 5 macetas regadas con Sol. C, se pulverizó con: mezcla M control (1 planta) , y mezcla Mb (4) . El efecto de cada uno de los tratamientos sobre la infección bacteriana en plantas de tomate se determinó mediante 2 aproximaciones: evaluación de síntomas 10 días después de haber realizado la infección, así como mediante determinación de supervivencia bacteriana a lo largo del tiempo mediante recuento de CFU. Se realizó un primer recuento 3 horas después de la infección para conocer el inoculo original y posteriormente se realizaron recuentos 3, 6, y 10 días después de la inoculación. Para el recuento de CFU de hojas infectadas con Pst DC3000, con ayuda de un sacabocados de 1 cm de diámetro, se aislaron 5 discos por hoja tratada, 1 por cada uno de los foliólos pulverizados (equivalente a una superficie total de hoja 3.9 cm2) . Los 5 discos se maceraron y homogenizaron en 1 mi de Cl2Mg 10 mM estéril, suspensión de la que se hicieron diluciones seriadas que se sembraron en placas de LB RiflO. El proceso se repite en la misma hoja tantas veces como el tamaño de la misma lo permita (3-6 veces), y se procede de la misma manera con la segunda hoja de la misma planta que también fue pulverizada. Así por cada tratamiento y tiempo de infección se realiza el recuento de 6-12 réplicas de las que se obtiene una media y error estándar. Of the 5 pots irrigated with Sol. E, it was sprayed with: ME control mixture (1 plant), and MEb mixture (4). Of the 5 pots irrigated with Sol. C, it was pulverized with: M control mixture (1 plant), and Mb mixture (4). The effect of each of the treatments on bacterial infection in tomato plants was determined by 2 approaches: evaluation of symptoms 10 days after the infection was performed, as well as by determination of bacterial survival over time by means of a CFU count . A first count was made 3 hours after infection to know the original inoculum and subsequently counts 3, 6, and 10 days after inoculation. For the CFU count of leaves infected with Pst DC3000, with the help of a punch of 1 cm in diameter, 5 discs were isolated per treated leaf, 1 for each of the pulverized leaflets (equivalent to a total leaf surface 3.9 cm 2 ). The 5 discs were macerated and homogenized in 1 ml of sterile 10 mM Cl 2 Mg, suspension of which serial dilutions were made that were seeded in LB RiflO plates. The process is repeated on the same sheet as many times as the size of it allows (3-6 times), and proceeds in the same way with the second sheet of the same plant that was also sprayed. Thus, for each treatment and time of infection the count of 6-12 replicas of which a mean and standard error is obtained is performed.
En la Fig. 4 se muestra la apariencia de las plantas transcurridos 10 días después de haber realizado los distintos tratamientos. Las plantas que se trataron con 2-TDC (MTlb y MTlOb) desarrollaron muchas menos manchas necróticas en la hojas que las plantas control (Mb y Eb) . El efecto además era dependiente de dosis, ya que las plantas tratadas con la solución de 2-TDC más concentrada (MTlOb) , mostraron mejor aspecto que las tratadas con una dosis de menor concentración, siendo casi inapreciable el desarrollo de manchas necróticas. El tratamiento con 2-TDC además tuvo efecto en la supervivencia bacteriana en los tejidos vegetales (Fig. 5) . Cuando la bacteria se aplicó en ausencia de 2-TDC (con agua o con etanol), la población alcanzó un máximo en torno a 107 unidades formadoras de colonia (CFU) por cm2 de hoja entre los 3 (agua) y 6 (etanol) días tras su aplicación, para posteriormente disminuir aproximadamente un orden de magnitud a los 10 días. En cambio, en las plantas tratadas con 2-TDC, la población bacteriana nunca llegó a alcanzar la densidad de 107 CFU por cm2, siendo especialmente llamativo el tratamiento con 500 μΜ de 2-TDC, que no permitió crecimiento bacteriano por lo que la densidad poblacional al final del experimento en plantas sometidas a este tratamiento, fue significativamente inferior en comparación con las demás. Fig. 4 shows the appearance of the plants after 10 days after performing the different treatments. Plants that were treated with 2-TDC (MTlb and MTlOb) developed much less necrotic spots on the leaves than control plants (Mb and Eb). The effect was also dose-dependent, since the plants treated with the more concentrated 2-TDC solution (MTlOb) showed a better appearance than those treated with a lower concentration dose, the development of necrotic spots being almost negligible. The 2-TDC treatment also had an effect on bacterial survival in plant tissues (Fig. 5). When the bacterium was applied in the absence of 2-TDC (with water or with ethanol), the population reached a maximum around 10 7 colony forming units (CFU) per cm 2 of leaf between 3 (water) and 6 ( ethanol) days after application, to subsequently decrease approximately an order of magnitude at 10 days. On the other hand, in plants treated with 2-TDC, the bacterial population never reached the density of 10 7 CFU per cm 2 , the treatment with 500 μΜ of 2-TDC being especially striking, which did not allow bacterial growth. The population density at the end of the experiment in plants subjected to this treatment was significantly lower compared to the others.
Por tanto, el tratamiento con 2-TDC protege a las plantas de tomate del desarrollo de una enfermedad causada por una bacteria . Therefore, treatment with 2-TDC protects tomato plants from the development of a disease caused by bacteria.
Ejemplo 2.- Aplicación de 2-TDC en solución nutritiva para reducir la infección causada por la bacteria Sinorhizobium meliloti en plantas de alfalfa. Como material vegetal se empleó alfalfa (Medicago sativa var . Aragón) . Las semillas se esterilizaron en superficie y se germinaron tal y como se describe en Olivares et al. (1980) . Las semillas germinadas se colocaron en tubos de vidrio (2 x 20 cm) conteniendo un papel de filtro y 10 mi de solución nutritiva para plantas carente de nitrógeno (Rigaud and Puppo, 1975) . Tras pasar 2 días en oscuridad, las plantas se trasladaron a una cámara de crecimiento bajo condiciones controladas de luz, Ta y humedad, en la que se incubaron 1 semana antes de proceder a la inoculación con la bacteria. Example 2.- Application of 2-TDC in nutrient solution to reduce infection caused by Sinorhizobium meliloti bacteria in alfalfa plants. Alfalfa (Medicago sativa var. Aragon) was used as plant material. The seeds were surface sterilized and germinated as described in Olivares et al. (1980). The germinated seeds were placed in glass tubes (2 x 20 cm) containing a filter paper and 10 ml of nutrient solution for nitrogen-free plants (Rigaud and Puppo, 1975). After spending 2 days in the dark, the plants were moved to a growth chamber under controlled conditions of light, T a and humidity, in which they were incubated 1 week before proceeding to inoculation with the bacteria.
Como bacteria capaz de infectar alfalfa, se utilizó la cepa GR4 de Sinorhizobium meliloti. El inoculo se preparó creciendo la bacteria en medio TY liquido (Beringer, 1974) a 30°C hasta alcanzar una densidad óptica (DC>6oonm) de 0.5-0.6 (aproximadamente 5 x 108 ufc/ml) . Este inoculo se diluyó en agua estéril para obtener una densidad de inoculo de 5 x 106 ufc/ml, suspensión con la que se realizaría la inoculación de las plantas. As a bacterium capable of infecting alfalfa, strain GR4 of Sinorhizobium meliloti was used. The inoculum was prepared by growing the bacteria in liquid TY medium (Beringer, 1974) to 30 ° C until reaching an optical density (DC> 6oonm) of 0.5-0.6 (approximately 5 x 10 8 cfu / ml). This inoculum was diluted in sterile water to obtain an inoculum density of 5 x 10 6 cfu / ml, suspension with which the inoculation of the plants would be performed.
Transcurridos 9-10 días de haber colocado las plántulas de alfalfa en los tubos, se procedió a la inoculación con la bacteria, adicionando a cada tubo/planta 1 mi de la suspensión bacteriana preparada como se ha mencionado previamente . After 9-10 days of placing the alfalfa seedlings in the tubes, the bacteria were inoculated, adding to each tube / plant 1 ml of the prepared bacterial suspension as previously mentioned.
En este ejemplo, la aplicación de los tratamientos con 2-TDC o tratamientos control (sólo etanol) se realizó al mismo tiempo de la inoculación con la bacteria. Para ello, se prepararon dos soluciones stock de 2-TDC utilizando etanol como disolvente: a 25 mM (5 mg de 2-TDC/ mi de etanol) y 5 mM (1 mg de 2-TDC/ mi de etanol) . 10 μΐ de una de estas soluciones se aplicaron a los 10 mi de solución nutritiva (dilución 1:1000) en que crecen las plantas, quedando por tanto el compuesto en una concentración de 25 μΜ y 5 μΜ, respectivamente . In this example, the application of 2-TDC treatments or control treatments (ethanol only) was performed at the time of inoculation with the bacteria. For this, two stock solutions of 2-TDC were prepared using ethanol as solvent: at 25 mM (5 mg of 2-TDC / ml of ethanol) and 5 mM (1 mg of 2-TDC / ml of ethanol). 10 μΐ of one of these solutions were applied to the 10 ml of nutrient solution (1: 1000 dilution) in which the plants grow, leaving therefore the compound in a concentration of 25 μΜ and 5 μΜ, respectively.
El éxito de la infección bacteriana se determinó realizando un conteo diario de los nodulos (órgano inducido y colonizado por S. meliloti) desarrollados por planta. En la Fig. 6 de esta memoria se muestran los resultados obtenidos en 2 experimentos independientes. Los datos sugieren que la aplicación de etanol a una concentración de 0.1% a la solución nutritiva en que crecen las plantas puede provocar un retraso en la aparición de nodulos, así como una reducción significativa en el n° medio de nodulos por planta, que no obstante se recupera con el tiempo, hasta alcanzar valores similares a los obtenidos en plantas en las que no se ha aplicado ningún tratamiento. No obstante, e interesantemente, la aplicación de la solución etanólica que contiene 2-TDC provoca un retraso y una reducción en el n° de nodulos, efectos que son significativamente superiores a los obtenidos con el tratamiento control, y además dependientes de dosis. La aplicación de la solución más concentrada de 2-TDC provocó un retraso de 4-6 días en la aparición de los primeros nodulos, asi como una reducción de casi el 50% en el n° de nodulos desarrollados . The success of the bacterial infection was determined by performing a daily count of the nodules (organ induced and colonized by S. meliloti) developed by plant. The results obtained in 2 independent experiments are shown in Fig. 6 of this report. The data suggest that the application of ethanol at a concentration of 0.1% to the nutrient solution in which the plants grow can cause a delay in the appearance of nodules, as well as a significant reduction in the average number of nodules per plant, which does not However, it recovers over time, until reaching similar values to those obtained in plants in which no treatment has been applied. However, and interestingly, the application of the ethanolic solution containing 2-TDC causes a delay and a reduction in the number of nodules, effects that are significantly superior to those obtained with the control treatment, and also dose dependent. The application of the more concentrated solution of 2-TDC caused a delay of 4-6 days in the appearance of the first nodules, as well as a reduction of almost 50% in the number of nodules developed.
Resultados similares se han obtenido aplicando 2-TDC a una concentración final de 25 μΜ 2 y 4 días antes de llevar a cabo la inoculación con la bacteria, asi como aplicando el producto 2 días después de haber realizado la inoculación bacteriana . Por el contrario el efecto protector no es observable cuando la aplicación se realiza 4 días después de haber puesto la bacteria en contacto con la planta. Similar results have been obtained by applying 2-TDC at a final concentration of 25 μΜ 2 and 4 days before carrying out the inoculation with the bacteria, as well as applying the product 2 days after the bacterial inoculation. On the contrary, the protective effect is not observable when the application is carried out 4 days after having put the bacteria in contact with the plant.
Ejemplo 3.- Comparación del efecto causado por las metilcetonas 2-undecanona, 2-dodecanona y 2-pentadecanona con el generado por la 2-tridecanona en la motilidad swarming de las bacterias Sinorhizobium meliloti GR4 y Pseudomonas syringae patovar syringae BTlll. Para comprobar si metilcetonas similares a la 2-tridecanona pueden tener el mismo efecto, y por tanto aplicaciones similares, se realizaron ensayos de motilidad en superficie de las bacterias S. meliloti GR4 y P. syringae pv. syringae BTlll, en ausencia y presencia de estos compuestos. Example 3.- Comparison of the effect caused by 2-undecanone, 2-dodecanone and 2-pentadecanone methyl ketones with that generated by 2-tridecanone in the swarming motility of the Sinorhizobium meliloti GR4 and Pseudomonas syringae patovar syringae BTlll bacteria. To check if methyl ketones similar to 2-tridecanone can have the same effect, and therefore similar applications, surface motility tests of S. meliloti GR4 and P. syringae pv bacteria were performed. syringae BTlll, in the absence and presence of these compounds.
El ensayo de motilidad en superficie se realizó básicamente como se describe en Nogales et al. 2010 BMC Genomics 11:157, con la única salvedad de que el medio mínimo (MM) semisólido se preparó añadiendo 0.6% de agar noble Difco (BD) en lugar de 0.6% agar purificado (Pronadisa) . Las placas se dejaron solidificar y secar durante 15 minutos en una cabina de flujo laminar con la tapa abierta antes de aplicar el inoculo. Las soluciones conteniendo cada una de las metilcetonas se prepararon disolviendo en 1 mi de etanol 50 μπιοΙθΞ de cada compuesto, o sea, 8,5 mg de 2-undecanona (2-UDC) , 9,2 mg de 2-dodecanona (2-DDC) , 10 mg de 2-tridecanona (2-TDC) o 11,32 mg de 2-pentadecanona (2-PDC) . The surface motility test was basically performed as described in Nogales et al. 2010 BMC Genomics 11: 157, with the sole caveat that the semi-solid minimum medium (MM) was prepared by adding 0.6% Difco noble agar (BD) instead of 0.6% purified agar (Pronadisa). The plates were allowed to solidify and dry for 15 minutes in a laminar flow cabinet with the lid open before applying the inoculum. The solutions containing each of the methyl ketones were prepared by dissolving 50 μπιοΙθΞ of each compound in 1 ml of ethanol, that is, 8.5 mg of 2-undecanone (2-UDC), 9.2 mg of 2-dodecanone (2- DDC), 10 mg of 2-tridecanone (2-TDC) or 11.32 mg of 2-pentadecanone (2-PDC).
Para la preparación del inoculo, las bacterias se crecieron en medio TY liquido (Beringer, 1974) a 30°C hasta alcanzar una densidad óptica (DC>6oonm) de 0.9-1. Bajo condiciones asépticas, se tomó 1 mL de estos cultivos y se recogieron las células mediante centrifugación (2 min, 10.000 rpm en una microcentrifuga) , desechándose el medio de cultivo libre ya de células. El precipitado de células se lavó 2 veces con 1 mi de MM liquido (Robertsen et al. 1981) y se resuspendió finalmente en 100 μΐ del mismo medio. Una alícuota de 2 μΐ de esta suspensión celular se colocó sobre la superficie del MM semisólido (preparado como se ha indicado anteriormente) y se dejó secar durante 10 min en cabina de flujo laminar con la tapa abierta. Transcurrido ese tiempo, se colocó en la tapa de la placa 20 μΐ de etanol o 20 μΐ de una solución conteniendo la metilcetona de larga cadena alifática, preparada como se ha indicado anteriormente. En el control no se aplicó nada. Se cerró la placa petri, se selló con parafilm, y se llevó a incubación a 28°C en oscuridad. Transcurridas 24 horas de incubación se midió el diámetro de dispersión de la colonia. Se han realizado al menos 3 réplicas técnicas. For the preparation of the inoculum, the bacteria were grown in liquid TY medium (Beringer, 1974) at 30 ° C until an optical density (DC> 6oonm) of 0.9-1 was reached. Under aseptic conditions, 1 mL of these cultures was taken and the cells were collected by centrifugation (2 min, 10,000 rpm in a microcentrifuge), discarding the cell-free culture medium. The cell precipitate was washed twice with 1 ml of liquid MM (Robertsen et al. 1981) and finally resuspended in 100 μΐ of the same medium. A 2 μΐ aliquot of this cell suspension was placed on the surface of the semi-solid MM (prepared as indicated above) and allowed to dry for 10 min in laminar flow cabinet with the lid open. After that time, 20 μΐ of ethanol or 20 μΐ of a solution containing the aliphatic long chain methyl ketone, prepared as indicated above, was placed on the plate lid. Nothing was applied in the control. The petri dish was closed, sealed with parafilm, and incubated at 28 ° C in the dark. After 24 hours of incubation, the dispersion diameter of the colony was measured. At least 3 technical replicas have been made.
En la Fig. 7 se muestran los resultados obtenidos. Se puede observar que salvo en el caso de 2-PDC que no promovió motilidad en la bacteria Pss BT111, las demás metilcetonas indujeron motilidad en superficie tanto en Sm GR4 como en Pss BT111, siendo la 2-DDC y 2-TDC las que provocaron mayor halo de dispersión de la colonia. Puesto que 2-UDC, 2-DDC y dependiendo de la bacteria también 2-PDC parecen tener un efecto promotor de la motilidad bacteriana en superficie similar al observado para 2-TDC, es esperable que el efecto preventivo de infecciones bacterianas pueda ser extrapolable a estas otras metilcetonas . The results obtained are shown in Fig. 7. It can be observed that except in the case of 2-PDC that did not promote motility in the Pss BT111 bacteria, the other methyl ketones induced surface motility in both Sm GR4 and Pss BT111, with 2-DDC and 2-TDC being the ones that caused largest colony dispersion halo. Since 2-UDC, 2-DDC and depending on the bacterium also 2-PDC seem to have a bacterial motility on the surface similar to that observed for 2-TDC, it is expected that the preventive effect of bacterial infections can be extrapolated to these other methyl ketones.
Ejemplo 4.- Aplicación de 2-TDC en superficie de alimentos de consumo humano o animal para evitar enfermedades causadas por bacterias patógenas que se encuentran contaminando el alimento . Example 4.- Application of 2-TDC on the surface of food for human or animal consumption to avoid diseases caused by pathogenic bacteria that are contaminating the food.
Se recolecta el alimento que en este caso puede ser un producto hortofruticola (frutas, verduras, hierbas...) o un producto de origen animal como el huevo susceptibles de estar contaminados con bacterias enteropatógenas como Salmonella. Posterior a un lavado con agua, los productos se hacen pasar por una cinta sobre la cual se aplica una lluvia de una solución acuosa que contiene 2-TDC a una concentración final de 50-500 uM. Cada litro de solución contiene 999 mi de agua, 1 mi de etanol y 10-100 mg de 2-TDC previamente disuelta en el etanol. The food is collected, which in this case can be a fruit and vegetable product (fruits, vegetables, herbs ...) or an animal product such as eggs that can be contaminated with enteropathogenic bacteria such as Salmonella. After a water wash, the products are passed through a belt on which a rain of an aqueous solution containing 2-TDC is applied at a final concentration of 50-500 µM. Each liter of solution contains 999 ml of water, 1 ml of ethanol and 10-100 mg of 2-TDC previously dissolved in ethanol.
Alternativamente al método de la cinta, los alimentos pueden ser sumergidos en cubetas conteniendo la misma solución. Una vez impregnados, se dejan secar a temperatura ambiente antes de proceder a su envasado. Alternatively to the tape method, food can be dipped in pails containing the same solution. Once impregnated, they are allowed to dry at room temperature before packing.
Ejemplo 5.- Empleo de inhaladores conteniendo 2-TDC en la prevención de enfermedades respiratorias bacterianas en pacientes con riesgo ( inmunodeprimidos , infecciones recurrentes...) Example 5.- Use of inhalers containing 2-TDC in the prevention of bacterial respiratory diseases in patients at risk (immunosuppressed, recurrent infections ...)
Preparar una suspensión de 2-TDC con concentración final entre 50-500 μΜ para su inhalación a través de un dispositivo a presión. Prepare a 2-TDC suspension with final concentration between 50-500 μΜ for inhalation through a pressure device.
Inhalar el preparado 1 o 2 veces al día. Inhale the preparation 1 or 2 times a day.

Claims

RE IVI DICACIONES RE IVI DICATIONS
1. Un método para prevenir y/o controlar infecciones bacterianas en una planta y/o cultivo, caracterizado porque comprende administrar al menos una metilcetona alifática de fórmula general (I)
Figure imgf000032_0001
1. A method to prevent and / or control bacterial infections in a plant and / or crop, characterized in that it comprises administering at least one aliphatic methyl ketone of general formula (I)
Figure imgf000032_0001
(I) (I)
donde R representa una cadena alifática formada por un número comprendido entre 9 y 13 átomos de carbono. where R represents an aliphatic chain formed by a number between 9 and 13 carbon atoms.
2. El método según la reivindicación anterior, donde la metilcetona es seleccionada dentro del grupo compuesto por 2- tridecanona, 2-dodecadona, 2-pentadecanona y 2-undecanona . 2. The method according to the preceding claim, wherein the methyl ketone is selected from the group consisting of 2- tridecanone, 2-dodecadone, 2-pentadecanone and 2-undecanone.
3. El método según una cualquiera de las reivindicaciones 1 ó 2, donde la metilcetona se administra en una solución que contiene dicha metilcetona en una concentración comprendida entre 1 μΜ y 10 mM, incluidos ambos limites. 3. The method according to any one of claims 1 or 2, wherein the methyl ketone is administered in a solution containing said methyl ketone in a concentration between 1 μ 1 and 10 mM, including both limits.
4. El método según la reivindicación anterior, donde la metilcetona se administra en una solución que contiene dicha metilcetona en una concentración comprendida entre 5 μΜ y 500 μΜ, incluidos ambos limites. 4. The method according to the preceding claim, wherein the methyl ketone is administered in a solution containing said methyl ketone in a concentration between 5 μΜ and 500 μΜ, including both limits.
5. El método según una cualquiera de las reivindicaciones 3 ó 4, donde la solución es etanólica. 5. The method according to any one of claims 3 or 4, wherein the solution is ethanolic.
6 . El método según una cualquiera de las reivindicaciones anteriores, donde la metilcetona se administra mediante un procedimiento de aplicación seleccionado dentro del grupo compuesto por: pulverización de la parte aérea de la planta, inyección directa en el tallo de la planta, administración directa al sustrato de crecimiento de la planta, administración a través del agua de riego o de una solución nutritiva, inmersión del sistema radicular o de la totalidad de la planta (o de semillas) en una solución que contiene la metilcetona, y cualquier combinación de dichos procedimientos . 6. The method according to any one of the preceding claims, wherein the methyl ketone is administered by an application method selected from the group consisting of: spraying the aerial part of the plant, direct injection into the plant stem, direct administration to the substrate of plant growth, administration through irrigation water or a solution nutritious, immersion of the root system or of the entire plant (or seeds) in a solution containing methyl ketone, and any combination of such procedures.
7. El método según una cualquiera de las reivindicaciones anteriores, donde la metilcetona se administra mezclada con aditivos seleccionados dentro del grupo compuesto por: fertilizantes orgánicos y/o inorgánicos, insecticidas, nematocidas, fungicidas, bactericidas y herbicidas, y cualquier combinación de los mismos; o bien se administra antes, después o simultáneamente a la administración de dichos aditivos. 7. The method according to any one of the preceding claims, wherein the methyl ketone is administered mixed with additives selected from the group consisting of: organic and / or inorganic fertilizers, insecticides, nematocides, fungicides, bactericides and herbicides, and any combination thereof ; or it is administered before, after or simultaneously to the administration of said additives.
8 . Un método para prevenir y/o controlar infecciones bacterianas en alimentos, instalaciones de producción y tratamiento de alimentos, instalaciones de contención, transporte y cuidado de animales, materiales e instalaciones médicas, y en materiales e instalaciones de hostelería, caracterizado porque comprende aplicar al menos una metilcetona alifática de fórmula general (I)
Figure imgf000033_0001
8. A method to prevent and / or control bacterial infections in food, food production and treatment facilities, containment, transport and care facilities for animals, medical materials and facilities, and hospitality materials and facilities, characterized in that it comprises applying at least an aliphatic methyl ketone of the general formula (I)
Figure imgf000033_0001
(I) (I)
donde R1 representa una cadena alifática formada por un número comprendido entre 9 y 13 átomos de carbono. where R 1 represents an aliphatic chain formed by a number between 9 and 13 carbon atoms.
9 . El método de la reivindicación anterior, donde la metilcetona es seleccionada dentro del grupo compuesto por 2- tridecanona, 2-dodecadona, 2-pentadecanona y 2-undecanona. 9. The method of the preceding claim, wherein the methyl ketone is selected from the group consisting of 2- tridecanone, 2-dodecadone, 2-pentadecanone and 2-undecanone.
10 . El método según una cualquiera de las reivindicaciones 8 ó 9, donde la metilcetona se administra en una solución que contiene dicha metilcetona en una concentración comprendida entre 1 μΜ y 10 mM, incluidos ambos límites. 10. The method according to any one of claims 8 or 9, wherein the methyl ketone is administered in a solution containing said methyl ketone in a concentration between 1 μ 1 and 10 mM, including both limits.
11. El método según la reivindicación anterior, donde la metilcetona se administra en una solución que contiene dicha metilcetona en una concentración comprendida entre 5 μΜ y 500 uM, incluidos ambos limites. 11. The method according to the preceding claim, wherein the methyl ketone is administered in a solution containing said methyl ketone in a concentration between 5 µΜ and 500 µM, including both limits.
12. El método según una cualquiera de las reivindicaciones 10 u 11, donde la solución es etanólica. 12. The method according to any one of claims 10 or 11, wherein the solution is ethanolic.
13. El método según una cualquiera de las reivindicaciones 8 a 12, donde la metilcetona se administra mediante un procedimiento de aplicación seleccionado dentro del grupo compuesto por: pulverización, inmersión, o dispersión mediante sistema de aire acondicionado y/o sistema de refrigeración. 13. The method according to any one of claims 8 to 12, wherein the methyl ketone is administered by an application method selected from the group consisting of: spraying, immersion, or dispersion by air conditioning system and / or cooling system.
14. Uso de al menos una metilcetona alifática de fórmula general ( I ) :
Figure imgf000034_0001
14. Use of at least one aliphatic methyl ketone of general formula (I):
Figure imgf000034_0001
(I) (I)
donde R1 representa una cadena alifática formada por un número comprendido entre 9 y 13 átomos de carbono, en la prevención y/o tratamiento de infecciones bacterianas en el campo fitosanitario o de la salud y la higiene de alimentos, materiales e instalaciones susceptibles de contaminación por bacterias patógenas. where R 1 represents an aliphatic chain formed by a number between 9 and 13 carbon atoms, in the prevention and / or treatment of bacterial infections in the phytosanitary field or the health and hygiene of food, materials and facilities susceptible to contamination by pathogenic bacteria.
15. Uso de la reivindicación anterior frente a patovares de una de las especies seleccionadas dentro del grupo compuesto por Pseudomonas syringae, P. savastanoi , Clavibacter michiganensis r Xanthomonas campestris, X. citri, Xylella fastidiosa, Ralstonia solanacearum, Agrobacterium turnefaciens r Erwinia amylovora r Salmonella typhimurium, Escherichia coli enteropatógenas , Proteus mirabilis , Pseudomonas aeruginosa y Legionella pneumophila. 15. Use of the preceding claim against pathovars of one of the species selected from the group consisting of Pseudomonas syringae, P. savastanoi, Clavibacter michiganensis r Xanthomonas campestris, X. citri, Xylella fastidiosa, Ralstonia solanacearum, Agrobacterium turnefaciens r Erwinia amylovo r Erwinia amylovo r Salmonella typhimurium, enteropathogenic Escherichia coli, Proteus mirabilis, Pseudomonas aeruginosa and Legionella pneumophila.
16. Uso de al menos una metilcetona alifática de fórmula general ( I ) :
Figure imgf000035_0001
16. Use of at least one aliphatic methyl ketone of general formula (I):
Figure imgf000035_0001
(I) (I)
donde R1 representa una cadena alifática formada por un número comprendido entre 9 y 13 átomos de carbono, en la prevención de biofilms en superficies, mediante administración sobre dicha superficies de un material. where R 1 represents an aliphatic chain formed by a number comprised between 9 and 13 carbon atoms, in the prevention of surface biofilms, by administration on said surfaces of a material.
17. Uso de al menos una metilcetona alifática de fórmula general ( I ) :
Figure imgf000035_0002
17. Use of at least one aliphatic methyl ketone of general formula (I):
Figure imgf000035_0002
donde R representa una cadena alifática formada por un número comprendido entre 9 y 13 átomos de carbono, como aditivo frente a infecciones bacterianas en productos de higiene oral o corporal. where R represents an aliphatic chain formed by a number between 9 and 13 carbon atoms, as an additive against bacterial infections in oral or body hygiene products.
18. Uso de la reivindicación anterior, donde el producto es seleccionado dentro del grupo compuesto por un dentífrico, un colutorio y un abón de manos. 18. Use of the preceding claim, wherein the product is selected from the group consisting of a dentifrice, a mouthwash and a hand fertilizer.
19. Uso de al menos una metilcetona alifática de fórmula general ( I ) :
Figure imgf000035_0003
(I)
19. Use of at least one aliphatic methyl ketone of general formula (I):
Figure imgf000035_0003
(I)
donde R1 representa una cadena alifática formada por un número comprendido entre 9 y 13 átomos de carbono, en la preparación de una composición farmacéutica o un medicamento para medicina. where R 1 represents an aliphatic chain formed by a number between 9 and 13 carbon atoms, in the preparation of a pharmaceutical composition or medicine for medicine.
20. Uso según la reivindicación anterior, en la prevención y/o tratamiento de infecciones bacterianas. 20. Use according to the preceding claim, in the prevention and / or treatment of bacterial infections.
21. Uso definido en una cualquiera de las reivindicaciones 14 a 20, donde la metilcetona es seleccionada dentro del grupo compuesto por 2-tridecanona, 2-dodecadona, 2-pentadecanona y 2-undecanona . 21. Use defined in any one of claims 14 to 20, wherein the methyl ketone is selected from the group consisting of 2-tridecanone, 2-dodecadone, 2-pentadecanone and 2-undecanone.
22. Una metilcetona alif rmula general (I) :
Figure imgf000036_0001
22. A methyl ketone alif general formula (I):
Figure imgf000036_0001
(I) (I)
donde R representa una cadena alifática formada por un número comprendido entre 9 y 13 átomos de carbono, para uso en medicina. where R represents an aliphatic chain formed by a number between 9 and 13 carbon atoms, for use in medicine.
23. Metilcetona según la reivindicación anterior, que es seleccionada dentro del grupo compuesto por 2-tridecanona, 2- dodecadona, 2-pentadecanona y 2-undecanona. 23. Methyl ketone according to the preceding claim, which is selected from the group consisting of 2-tridecanone, 2-dodecadone, 2-pentadecanone and 2-undecanone.
24. Metilcetona según una cualquiera de las reivindicaciones 22 ó 23, para uso en la prevención y/o control de infecciones bacterianas en un sujeto. 24. Methyl ketone according to any one of claims 22 or 23, for use in the prevention and / or control of bacterial infections in a subject.
25. Metilcetona según la reivindicación anterior, donde el sujeto es un animal o un ser humano. 25. Methyl ketone according to the preceding claim, wherein the subject is an animal or a human being.
26. Metilcetona según una cualquiera de las reivindicaciones 22 a 25, donde la metilcetona se aplica en una solución que contiene dicha metilcetona en una concentración comprendida entre 1 μΜ y 10 mM, incluidos ambos limites. 26. Methyl ketone according to any one of claims 22 to 25, wherein the methyl ketone is applied in a solution containing said methyl ketone in a concentration between 1 μΜ and 10 mM, including both limits.
27 . Metilcetona según la reivindicación anterior, donde la metilcetona se aplica en una solución que contiene dicha metilcetona en una concentración comprendida entre 5 μΜ y 500 uM, incluidos ambos limites. 27. Methyl ketone according to the preceding claim, wherein the methyl ketone is applied in a solution containing said methyl ketone in a concentration between 5 μΜ and 500 μM, including both limits.
28 . Metilcetona según una cualquiera de las reivindicaciones 26 ó 27, donde la solución es etanólica. 28. Methyl ketone according to any one of claims 26 or 27, wherein the solution is ethanolic.
29 . Metilcetona según una cualquiera de las reivindicaciones anteriores, donde la metilcetona se administra frente a una de las especies seleccionadas dentro del grupo compuesto por Salmonella typhimurium, Escherichia coli enteropatógenas , Proteus mirabilis r Pseudomonas aeruginosa y Legionella pneumophila . 29. Methyl ketone according to any one of the preceding claims, wherein methyl ketone is administered against one of the species selected from the group consisting of Salmonella typhimurium, enteropathogenic Escherichia coli, Proteus mirabilis r Pseudomonas aeruginosa and Legionella pneumophila.
PCT/ES2013/070570 2012-08-01 2013-07-31 Method for preventing and/or controlling bacterial infections WO2014020224A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES201231248A ES2445491B1 (en) 2012-08-01 2012-08-01 Method to prevent and / or control bacterial infections
ESP201231248 2012-08-01

Publications (1)

Publication Number Publication Date
WO2014020224A1 true WO2014020224A1 (en) 2014-02-06

Family

ID=50027321

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ES2013/070570 WO2014020224A1 (en) 2012-08-01 2013-07-31 Method for preventing and/or controlling bacterial infections

Country Status (2)

Country Link
ES (1) ES2445491B1 (en)
WO (1) WO2014020224A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108056160A (en) * 2017-12-15 2018-05-22 丹阳市三木果业有限公司 A kind of nutrient solution for apple accumulating

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001348308A (en) * 2000-03-13 2001-12-18 Lion Corp Bacterial metabolism inhibitor
JP2011148775A (en) * 2009-12-21 2011-08-04 Tablemark Co Ltd Antibacterial substance, mold preventive, food preservative, yeast extract, bactericide, method for inhibiting proliferation of mold and/or yeast, and method for inhibiting growth of yeast and/or bacterium

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001348308A (en) * 2000-03-13 2001-12-18 Lion Corp Bacterial metabolism inhibitor
JP2011148775A (en) * 2009-12-21 2011-08-04 Tablemark Co Ltd Antibacterial substance, mold preventive, food preservative, yeast extract, bactericide, method for inhibiting proliferation of mold and/or yeast, and method for inhibiting growth of yeast and/or bacterium

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI 10 October 2013 Derwent World Patents Index; AN 2011-J80472, THOMSON SCIENTIFIC *
DATABASE WPI 11 October 2013 Derwent World Patents Index; AN 2002-247345, THOMSON SCIENTIFIC *
HADJ FREDJ ET AL.: "Analysis of tunisian Ruta graveolensL. oils from Jemmel", JOURNAL OF FOOD AGRICULTUREAND ENVIRONMENT, vol. 5, no. 1, 2007, pages 52 - 55 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108056160A (en) * 2017-12-15 2018-05-22 丹阳市三木果业有限公司 A kind of nutrient solution for apple accumulating

Also Published As

Publication number Publication date
ES2445491A1 (en) 2014-03-03
ES2445491B1 (en) 2015-03-09

Similar Documents

Publication Publication Date Title
ES2926368T3 (en) Use of hydroxyapatite as a carrier of bioactive substances to treat vascular diseases in plants
CN104756800A (en) Purpose of allyl isothiocyanate for disinfection of panax notoginseng continuous cropping soil
US7582318B2 (en) Natural composition based on Chilean monofloral honey extract from native vegetable species for bacterial infection control in vegetables at all
CN101300986B (en) Biological insecticide
BRPI0617067A2 (en) controlled acid composition
CN107427011A (en) Prevent in crops and ornamental plant, the method for the infection preferably in wine-growing and xylophyta
O’Keeffe et al. Antibacterial activity of seaweed extracts against plant pathogenic bacteria
CN103012237B (en) Amino-acid dual-chain quaternary-amino carboxylate, preparation method and application in microbicides thereof
ES2735732T3 (en) New bacterial strains of the species Bacillus amyloliquefaciens and related applications
CN102106347A (en) Cinnamaldehyde, eugenol, thymol and tannin compound bactericide
CN105010401A (en) Seed treating agent adopting microorganisms
KR20160043547A (en) Natural disinfection for horticultural crops produced thereby and method of manufacturing pesticides and natural disinfection and pesticides
CN101926830B (en) Antibacterial agent
ES2924416T3 (en) An ecological disinfectant composition for agricultural soils comprising a mixture of Capsicum extract, calendula extract and garlic extract
WO2014020224A1 (en) Method for preventing and/or controlling bacterial infections
US11805784B2 (en) Use of hydroxyapatite as a carrier of bioactive substances for treating vascular diseases in plants
CN109221223A (en) A kind of safe and efficient composite disinfectant
Allahinejad et al. Evaluation of the antibacterial potential of Scrophularia striata against plant pathogenic bacteria
RU2433589C1 (en) Method to control larvae of bloodsucking insects
KR20210014043A (en) 10% benzalkonium chloride disinfectant and disinfectant composition containing clove oil
Deblais Understanding of Salmonella-phytopathogen-environment-plant interactions and development of novel antimicrobial to reduce the Salmonella burden in fresh tomato production
BR102021021042A2 (en) BIOACTIVE COMPOSITION OF HERMETIA ILLUCENS LARVA EXTRACT WITH APPLICATION FOR THE CONTROL OF COCOA PHYTOPATHOGENS CERATOCYSTIS CACAOFUNESTA, MONILIOPHTHORA PERNICIOSA AND PHYTOPHTHORA PALMIVORE
CN106259434B (en) Bactericidal mixed agent formula for enhancing control effect of thiophanate-methyl and preparation method thereof
BR102021014300A2 (en) METHOD OF PREPARATION OF INACTIVATED BACTERIAL SUSPENSION FOR THE CONTROL OF TOMATO BACTERIAL SPOT
Alderete Post-Harvest Spray Treatments to Reduce Salmonella Contamination on Cantaloupe Surfaces

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13825241

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13825241

Country of ref document: EP

Kind code of ref document: A1